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ABSTRACT  
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Eukaryotic cells have evolved tightly controlled processes that make sure the entire genome 
gets replicated accurately, once per cell cycle. This tight control is fulfilled by degrading 
replication proteins after their function is carried out, changing their cellular location or by post-
translational modification of replication factors to regulate their function. Phosphorylation events 
carried out by CDKs (cyclin dependent kinases) and DDKs (Dbf4 dependent kinases) play crucial 
roles in this regulation.  
The DNA unwinding element binding protein (DUE-B) is an essential replication protein 
that binds to the human c-myc DNA replication origin. In this study, I find that DUE-B is also 
actively regulated by kinases and phosphatases. DUE-B binds to chromatin after pre-replication 
complex formation but before Cdc45 chromatin loading. DUE-B chromatin binding requires 
CDK activity but it is inhibited by the DNA replication checkpoint response. DDK and PP2A are 
identified in this study as the primary kinase-phosphatase pair that controls DUE-B 
phosphorylation. Cdk2 and CKII also phosphorylate DUE-B at the C-terminus domain. Here I 
show that DUE-B is phosphorylated during the G1-S phase of the cell cycle and gets 
dephosphorylated in G2-M phases. Phosphorylation on DUE-B controls its function in supporting 
DNA replication. Specifically, dephosphorylated DUE-B can interact with MCM2-7 complex and 
inhibit DNA replication. The DUE-B C-terminus domain is very rich in serine and threonine, 
which can be phosphorylated by many kinases. Here I show that phosphorylation at the C-
terminus domain can actively control the protein activity in supporting DNA replication and cell 
survival. 
 
	   v	  
Table of Contents 
INTRODUCTION .............................................................................................................. 1 
DNA replication origin ................................................................................................................ 1 
DNA replication initiation in eukaryotic organisms .................................................................... 3 
Finding the Sld2 and Sld3 ortholog in higher organisms ............................................................ 6 
DNA replication checkpoint response ......................................................................................... 7 
DNA Unwinding Element Binding protein, DUE-B ................................................................. 11 
MATERIALS AND METHODS ...................................................................................... 13 
Preparation of Xenopus egg extracts ......................................................................................... 13 
Preparation of demembranated Xenopus sperm chromatin ....................................................... 14 
Chromatin binding of DNA replication factors ......................................................................... 15 
Immunodepletion of protein from Xenopus egg extracts .......................................................... 16 
DNA replication assay using agarose gel electrophoresis ......................................................... 16 
Construction of plasmids ........................................................................................................... 17 
Site directed mutagenesis .......................................................................................................... 17 
Preparation of ultra-competent cells .......................................................................................... 18 
Protein purification .................................................................................................................... 18 
Antibody affinity purification .................................................................................................... 19 
Protein kinase assay ................................................................................................................... 20 
Size-exclusion chromatography ................................................................................................ 20 
Western blotting ........................................................................................................................ 21 
Immunoprecipitation and co-immunoprecipitation ................................................................... 21 
Cell culture and Cell transfection .............................................................................................. 22 
Flow cytometry .......................................................................................................................... 22 
Fluorescence microscopy .......................................................................................................... 23 
Colony forming assay ................................................................................................................ 23 
RESULTS ......................................................................................................................... 24 
I. DUE-B is recruited onto replication origin after pre-RC formation ...................................... 24 
Sequential binding of replication proteins onto chromatin during replication initiation ....... 24 
DUE-B binding to chromatin requires pre-RC formation and s-phase CDK activity ........... 28 
DUE-B is necessary for Cdc45 and TopBP1 chromatin binding .......................................... 31 
Summary .................................................................................................................................... 34 
	   vi	  
II. Replication checkpoint negatively regulates DUE-B binding onto chromatin ..................... 36 
The checkpoint activated by aphidicolin inhibits both Cdc45 and DUE-B chromatin binding
 ............................................................................................................................................... 36 
Checkpoint induced by etoposide inhibits DUE-B chromatin loading .................................. 40 
DUE-B chromatin loading is moderately sensitive to DNA double strand break ................. 45 
Protein phosphatase 2A is required for DUE-B chromatin binding ...................................... 45 
Under phosphorylated DUE-B is regulated differently from endogenous Xenopus DUE-B 48 
DUE-B or Orc2 is not necessary for checkpoint activation ................................................... 51 
Summary .................................................................................................................................... 53 
III. DUE-B can be phosphorylated during replication initiation ............................................... 53 
Endogenous DUE-B is phosphorylated during replication initiation .................................... 54 
DUE-B can be phosphorylated at threonine 187 by Cdk2 in vitro ........................................ 59 
Summary .................................................................................................................................... 60 
IV. DUE-B is part of high molecular weight complexes during certain phases of the cell cycle
 ................................................................................................................................................... 65 
Endogenous DUE-B is incorporated into high molecular weight complexes during certain 
phases of the cell cycle .......................................................................................................... 65 
DUE-B in homodimer is sensitive to phosphatase treatment ................................................ 70 
Summary .................................................................................................................................... 73 
V. Incorporation of DUE-B into high molecular weight complexes is controlled by multiple 
kinases and phosphatase ............................................................................................................ 73 
DUE-BSf9 forms high molecular weight complexes in G1 phase egg extract ....................... 74 
Phosphorylation regulates DUE-BSf9 incorporation into high molecular weight complexes 76 
DDK and PP2A control DUE-B phosphorylation in G1 phase egg extract .......................... 81 
DNA damage checkpoint response regulates DUE-B binding with other protein ................ 90 
Summary .................................................................................................................................... 93 
VI. MCM 2-7 is part of the high molecular weight complexes ................................................. 95 
DUE-BSf9 binds to many proteins in high molecular weight complexes ............................... 95 
DUE-B and Mcm3/5 co-immunoprecipitate with each other ................................................ 96 
DUE-B forms more than one high molecular weight complexes in Xenopus egg extract .. 101 
Summary .................................................................................................................................. 103 
VII. Phosphorylation at the C-terminus is important for regulating the activity of DUE-B ... 103 
C-terminus domain regulates DUE-B subcellular localization ............................................ 104 
Phosphorylation at DUE-B C-terminus is critical for DNA replication and cell growth .... 107 
	   vii	  
Summary .................................................................................................................................. 116 
DISCUSSION ................................................................................................................. 119 
I. DUE-B is an essential replication factor required for Cdc45 chromatin binding ................ 119 
II. DNA replication checkpoint inhibits DUE-B chromatin binding ....................................... 123 
III. Dephosphorylated DUE-B is incorporated into high molecular weight complexes ......... 126 
IV. Kinase and phosphatase equilibrium controls DUE-B phosphorylation ........................... 128 
V. C-terminus domain is important for DUE-B function ........................................................ 132 
VI. Regulation DUE-B activity during the cell cycle .............................................................. 135 
CONCLUSIONS ............................................................................................................ 137 
APPENDICES ................................................................................................................ 138 
REFERENCES ............................................................................................................... 148 
	  
	  
	   	  
	   viii	  
LIST	  OF	  FIGURES	  	  
Figure 1. DUE-B binds to chromatin at the same time as Cdc45 and is released after replication 
initiation  …………………………………………………………………………………………26 
Figure 2. DUE-B binding to chromatin is inhibited by geminin…………………………………29 
Figure 3. DUE-B, Cdc45, TopBP1 and Mcm7 binding to chromatin is inhibited by roscovitine.30 
Figure 4. DUE-B depletion inhibits Cdc45 loading onto chromatin  ……………………………32 
Figure 5. DUE-B does not interact with Cdc45 or TopBP1 in G1 phase Xenopus egg extract …35 
Figure 6. Low level of aphidicolin induces an ATR/Chk1 checkpoint while high concentration of 
aphidicolin inhibits Chk1 phosphorylation………………………………………………………37 
Figure 7. Checkpoint response activated by aphidicolin inhibits DUE-B and Cdc45 binding to 
chromatin…………………………………………………………………………………………39 
Figure 8. Etoposide inhibits DUE-B and Cdc45 loading onto chromatin. The inhibition cannot be 
reversed by caffeine………………………………………………………………………………41 
Figure 9. poly(dA)70-poly(dT)70 inhibits DUE-B loading onto chromatin ………………………46 
Figure 10. Okadaic acid inhibits DUE-B loading onto chromatin  ………………………………47 
Figure 11. DUE-BSf9 hyper loads onto chromatin and is regulated differently from the 
endogenous DUE-B………………………………………………………………………………50 
Figure 12. DUE-B is not involved in checkpoint activation   ……………………………………52 
Figure 13. Endogenous Xenopus DUE-B can be phosphorylated during replication initiation.…56 
Figure 14. DUE-B phosphorylation level increases in S-phase human cells. ……………………57 
Figure 15. Cdk2 can phosphorylate DUE-B purified from different source at different level...…61 
Figure 16. Cdk2 can phosphorylate WT DUE-B but not C-terminus truncated DUE-B…………62 
Figure 17. Cdk2-cyclinA phosphorylates DUE-B in vitro at T187. Phosphorylated DUE-B 
migrates faster on SDS-PAGE……………………………………………………………………63 
Figure 18. Cdk2 kinase activity can be specifically inhibited by p27   ………………………… 64 
 
	   ix	  
Figure 19. A fraction of DUE-B was incorporated in a high molecular weight complex in M 
phase HeLa cells…………………………………………………………………………………66 
Figure 20. A fraction of DUE-B is part of a high molecular weight complex in M phase Xenopus 
egg extract. DUE-B in high molecular weight complex shows a mobility shift…………………68 
Figure 21. DUE-B that forms dimer is susceptible to phosphatase modification and showed slight 
mobility shift after phosphatase treatment  ………………………………………………………71 
Figure 22. A fraction of DUE-BSf9 can be incorporated into a high molecular weight complex 
when incubated with G1 phase egg extract ………………………………………………………75 
Figure 23. Endogenous DUE-B does not regulate DUE-BSf9 distribution………………………77 
Figure 24. The amount of DUE-B in high molecular weight complex is not related to the amount 
of exogenous DUE-B added into the reaction……………………………………………………78 
Figure 25. Phosphorylation by Casein Kinase II moves DUE-B into dimmer form……………  80 
Figure 26. High molecular weight complex formation is a result of phosphatase activity………82 
Figure 27. High molecular weight complex formation is greatly inhibited by okadaic acid…… 83 
Figure 28. Inhibition of Cdc7 by PHA-767491 is able to cancel the effect of okadaic acid and 
bring Sf9-DUE-B into the high molecular weight complex……………………………………  85 
Figure 29. Inhibition of CKII by TBB or inhibition of Cdk2 by p27 is not sufficient to antagonize 
the effect of okadaic acid. ………………………………………………………………………86 
Figure 30. Multi organism alignment of DUE-B C-terminus tail amino acid sequences………88 
Figure 31. CKII primes the DUE-B C-terminus for phosphorylation by DDK…………………89 
Figure 32. Checkpoint activated by dAdT greatly shifts DUE-B into high molecular weight 
complex. ………………………………………………………………………………………… 91 
Figure 33. Okadaic acid reverses the effect of dAdT ……………………………………………92 
Figure 34. Adding AMP-PNP to egg extract would not change the distribution of DUE-BSf9.. 94 
Figure 35. WRSU7 antibody production and antibody affinity purification……………………  98 
Figure 36. Xenopus Mcm3 and Mcm5 co-IP with DUE-BSf9 in G1 phase egg extract…………99 
	   x	  
Figure 37. DUE-B forms more than one high molecular complex in egg extract………………102 
Figure 38. ΔCT DUE-B has different sub-cellular localization from the WT DUE-B…………105 
Figure 39. IVT translated DUE-B lacks the modification that keeps endogenous DUE-B in the 
dimer form. ……………………………………………………………………………………  108 
Figure 40. DUE-B C-terminus domain mutants………………………………………………   109 
Figure 41. Phosphorylation of C-terminus S/T residues is important for cell grow……………111 
Figure 42. S/T-A mutant induces slight increasing in sub G1 and S phase cells in asynchronous 
population………………………………………………………………………………………112 
Figure 43. S/T-A DUE-B purified from HeLa cells dominantly inhibited DNA replication when 
added into Xenopus egg extract…………………………………………………………………114 
Figure 44. Phosphorylation of C-terminus of DUE-B regulates its activity in DNA replication 
initiation ………………………………………………………………………………………   115 
Figure 45. Dephosphorylating of DUE-B C-terminus decreases the level of disorder at the C-
terminus. ………………………………………………………………………………………  117 
Figure 46. Model of DUE-B chromatin loading during DNA replication initiation……………122 
Figure 47. Structural analysis of DUE-B N-terminus and MCM4-DDK docking site…………130 
Figure 48. Phosphorylation at the DUE-B C-terminus domain changes its structure…………  134 
Figure 49. Regulation of DUE-B through out the cell cycle……………………………………136 
Appendix 1. Xenopus egg extract preparation.…………………………………………………138 
Appendix 2. Optimizing nocodazole concentration and centrifugation condition to inhibit non-
specific precipitation in Xenopus egg extract system…………………………………………  139 
Appendix 3. Site directed mutagenesis…………………………………………………………140 
Appendix 4. Testing TopBP1 antibody WRSU5 rabbit serum was made by Casey Wells……141 
Appendix 5. Optimizing the siRNA transfection condition for human fibroblast cells………  142 
Appendix 6. Examples of purified proteins in this study………………………………………143 
Appendix 7. Chemical tolerance test of Xenopus egg extract…………………………………144 
	   xi	  
Appendix 8. Plasmids used in this study………………………………………………………  145 
 
Table 1. Mass spectrometry analysis of Xenopus proteins binding to DUE-BSf9 in the high 
molecular weight complex……………………………………………………………………… 97 
Table 2. Mutagenesis PCR primers used in this study. …………………………………………146  
	   xii	  
ACKNOWLEDGMENTS  
 
I wish to thank Dr. Michael Leffak for providing help, guidance, and an excellent training 
environment, all of which has been invaluable in my development as a scientist. I would like 
also to recognize Drs. Michael Kemp, Guoqi Liu and Asif Chowdhury for their assistance 
and collaborations, and for performing much of the background work that allowed me to 
propose and carry out many of the experiments in this dissertation. Additionally, I would like 
to appreciate Dr. Ming Yue and Ms. Jianhong Yao for their generous assistance in lab 
technique and scientific skills. Lastly, the comments, criticisms, and ideas offered by all the 
other members of the Leffak laboratory with whom I have worked are greatly appreciated.  
  





To my wife Danjie Song, 
 





DNA replication is the most important event for dividing cells since this process duplicates the 
genetic information that controls every cellular event in almost all living organisms. Inaccuracy 
during this event may lead to lethality or genomic instability for cells. For unicellular organisms, 
alteration of genetic information encoded in DNA most commonly could lead to death of 
individual cells. For multi-cellular organisms, errors in DNA replication can lead to inheritable 
diseases and cancer.  As a result, nature has evolved sophisticated mechanisms to ensure the 
fidelity of DNA replication, many of which are conserved throughout evolution. By using yeast, 
Drosophila and Xenopus as model systems, we have learned a tremendous amount of knowledge 
regarding the mechanisms of eukaryotic DNA replication.  
DNA replication origin 
DNA replication initiates from segments on the chromosome, termed replication origins, 
during every cell cycle. The locations of DNA replication origins on chromatin are not random in 
most organisms. For example, in over 12 million base pairs of the budding yeast Saccharomyces 
cerevisiae genome, only about 700 replication origins were identified using different mapping 
methods (Wyrick, Aparicio et al. 2001; Xu, Aparicio et al. 2006; Nieduszynski, Hiraga et al. 
2007). Every replication origin identified in budding yeast contains the conserved elements called 
autonomously replicating sequences (ARS) (Marahrens and Stillman 1992). The ARS features in 
a well-conserved 11 base pairs A element and less conserved B1, B2 and B3 elements (Dhar, 
Sehgal et al. 2012). In human cells, 283 potential replication origins were identified in 1% of 
entire genome (Cadoret, Meisch et al. 2008). However, no consensus sequence has been 
identified in human replication origins. Consequently, only a few replication origins have been 
well characterized in human cells (Leffak and James 1989; Liu, Malott et al. 2003; Paixão, 
Colaluca et al. 2004). Although no homology has been observed on the DNA sequence for 
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replication origins, the function of replication origins are the same. They always act as a cis 
element for replication initiation. 
The most common property of replication origins identified from different organisms is that 
they all contain stretches of AT rich DNA sequences relative to the rest of the genome (Kowalski, 
Natale et al. 1988; Natale, Umek et al. 1993). One possibility is that the AT rich region forms a 
special structure that could be recognized by DNA replication factors. Indeed, fission yeast Orc4 
preferentially binds to the AT rich region through its AT hook motif (Chuang and Kelly 1999; 
Lee, Moon et al. 2001). Moreover, budding yeast AT rich ACS sequence is required for ORC 
binding to the ARS (Bell and Stillman 1992). On the other hand, because the AT rich DNA is 
energetically easier to denature, it might act as a more favorable substrate for MCM 
(minichromosome maintenance) helicase to unwind double stranded DNA than the rest of the 
genome. Consistent with this hypothesis, our lab showed that easy unwinding (ATTCT)n repeats 
could functionally replace the human DNA unwinding element (DUE) in the c-myc replication 
origin suggesting that the ease of DNA unwinding is more important than the DNA sequence in 
the DUE (Liu, Bissler et al. 2007). The two mechanisms are not mutually exclusive and may 
work together to recruit DNA replication proteins onto the replication origin.  
Replication origin activation is regulated in a specific temporal order throughout the entire 
S-phase. There are many potential DNA replication origins on chromatin, but only a fraction of 
them are used during a normal cell cycle while the rest of the origins are replicated passively 
(active origins vs. dormant origins) (Woodward, Luciani et al. 2006). Among the origins that are 
used during the normal cell cycle, only a subset of them fire at the onset of S-phase (early origins 
vs. late origins) (Jeon, Bekiranov et al. 2005). The selection of origin during normal cell cycle is 
likely related to the chromatin structure because early origins are usually detected in regions 
where many genes are actively transcribed. Consistently, our lab found that artificial recruitment 
of transcription factor E2F1 to chromatin facilitates origin firing in that region (Xiaomi Chen, 
unpublished data). Transcription factors and histone acetyltransferases potentially “open up” the 
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chromatin to make it accessible to transcription machinery as well as DNA replication factors. 
Additionally, we reported that histone deacetylase inhibitor TSA augments global DNA 
replication in human cells (Santocanale and Diffley 1998; Kemp, Ghosh et al. 2005).  
Importantly, when DNA replication is challenged, late origin firing is prevented by the 
activation of the intra-S-phase checkpoint (Santocanale and Diffley 1998; Dimitrova and Gilbert 
2000). Inhibition of the late replication origins firing will prevent accumulation of DNA 
replication intermediates under stressful conditions and thus reduces the chance of introducing 
errors into newly synthesized DNA. Meanwhile, if the DNA replication checkpoint response is 
attenuated after replication challenge has been removed, many dormant origins that were not used 
in the regular cell cycle will be activated (Woodward, Luciani et al. 2006).     
DNA replication initiation in eukaryotic organisms  
Eukaryotic DNA replication initiation is divided into two steps: replication origin 
licensing, and replication complex activation (Appendix 9). The first step of licensing is 
chromatin binding of the Origin Recognition Complex (ORC), which is identified by Bell and 
Stillman as a yeast protein complex that can bind DNA and protect the ARS from enzyme 
digestion in DNA footprinting experiments (Bell and Stillman 1992). ORC consists of six 
subunits (Orc1-6) which recognizes the sites of replication origin along the chromosome 
(DePamphilis 2005). Homologs of all ORC subunits have been identified in all eukaryotic 
replication model systems. Chromatin bound ORC acts as a platform recruiting other proteins to 
the potential replication origin. However, ORC does not move along with the replication fork and 
is inactivated by degradation of the Orc1 subunit in S phase of cell cycle (Mendez, Zou-Yang et 
al. 2002).  
Cdc6 (cell division cycle protein 6) and Cdt1 (Cdc10 dependent transcript 1) are the first 
two proteins recruited to ORC and ORC/Cdc6/Cdt1 act together to load the ring shaped MCM 
complex (the putative replicative DNA helicase) onto chromatin. Cdc6 physically interacts with 
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ORC and forms an ORC/Cdc6 complex which hydrolyzes ATP to facilitate MCM loading 
(Harvey and Newport 2003). Multiple Cdt1 molecules interact with the MCM complex at the C-
terminus of Cdt1 and load MCM onto chromatin (Takara and Bell 2011). Cdc6 and Cdt1 are the 
key regulators that ensure DNA gets replicated once and only once per cell cycle. As a result, 
their protein level and activity is strictly limited to the stage of replication origin licensing and 
before replication initiation.  In yeast S. cerevisiae, as a result of elevated S phase cyclin 
dependent kinases activity, Cdc6 is phosphorylated and is targeted to degradation (Drury, Perkins 
et al. 2000) while Cdt1 is exported from the nucleus after replication initiation (Labib, Diffley et 
al. 1999).  In metazoans, Cdt1 is degraded or its activity is inhibited by binding to Geminin after 
replication initiation (Blow and Dutta 2005).  
The MCM complex, which contains Mcm2-7 subunits, is highly conserved throughout 
the eukaryotic kingdom. It has been long thought to be the DNA double strand unwinding 
helicase but purified MCM complex only showed limited helicase activity. Mcm2-7 subunits are 
able to form various different sub-complexes for example Mcm4/6/7 can be purified as a hexamer 
and has limited 3’ to 5’ DNA helicase activity in vitro (Ishimi 1997). However, all six subunits 
are required for DNA replication in Xenopus egg extracts (Prokhorova and Blow 2000) and for 
viability of yeast S. cerevisiae (Schwacha and Bell 2001) . Now we know the hetero-hexamer 
needs to be activated during the G1-S transition by posttranslational modifications and requires 
several activation partners such as GINS and Cdc45. A recent study indicates that MCM complex 
is loaded onto chromatin as a pair of hexamers in a head to head manner (Hirano and Mitchison 
1993). When activated, each MCM hexamer (Mcm2-7) can act as a single helicase to open up 
double stranded DNA for polymerase to bind (Yardimci, Loveland et al. 2010). 
Importantly, loading of MCM onto chromatin and activating its helicase activity are two 
strictly separated processes during different cell cycle. MCM chromatin loading can only happen 
at the late M to G1 phase of cell cycle when CDK and DDK kinase activity is low (Bell and Dutta 
2002). During the G1-S phase transition, the kinase activity of CDK and DDK elevates and keeps 
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high though out the entire S-phase. Active CDK and DDK phosphorylate a series of substrates to 
promote the loading of MCM activators. DDK is the first kinase activated during the G1-S 
transition. It promotes S phase by alleviating an inhibitory activity in N-terminus of Mcm4 (Sheu 
and Stillman 2010). Phosphorylated MCM complex is able to interact with helicase activating 
protein Cdc45 (Cell division cycle protein 45) and GINS (Sld5, Psf1, Psf2, Psf3) (Zou and 
Stillman 2000). CDK facilitates loading of Cdc45 onto MCM complex by phosphorylating Sld2 
and Sld3. Phosphorylated Sld2 and Sld3 interacts with Cut5 (budding yeast ortholog of human 
TopBP1) to recruit Cdc45 and GINS to MCM complex (Zegerman and Diffley 2007). After 
loading onto chromatin, Cdc45 physically interacts with MCM and activates the helicase activity 
of the MCM complex (Pacek and Walter 2004; Ilves, Petojevic et al. 2009). The CMG (Cdc45-
MCM-GINS) complex is called the pre-initiation complex (pre-IC). Once the CMG complex is 
formed, MCM helicase is able to unwind double stranded DNA. Then RPA (Replication Protein 
A) is recruited to coat the single stranded unwound DNA, polymerase α primes DNA synthesis 
on both strand, whereas polymerase ε and polymerase δ replicate leading and lagging strand 
respectively (Burgers 2009).  
Among all the replication factors, fluctuation of protein phosphorylation levels is the 
major force driving the cell cycle forward, which is tightly controlled by balancing between 
kinases and phosphatases (Coudreuse and Nurse 2010; Krasinska, Domingo-Sananes et al. 2011; 
Gillespie, Gambus et al. 2012). In the event of DNA replication, DDK and CDK are the most 
important kinases. DDK phosphorylation on the chromatin bound MCM complexes is essential 
for the MCM to bind with the helicase activator Cdc45 (Hardy, Dryga et al. 1997). CDK 
phosphorylates Sld2 and Sld3 in yeast to promote their interaction with TopBP1, which is also 
necessary for Cdc45 chromatin loading (Zegerman and Diffley 2007). The ultimate goal of CDK 
and DDK phosphorylation is to activate the helicase activity of MCM complex. Besides CDK and 
DDK, casein kinase II (CKII) has emerged to be an important kinase regulating DNA replication 
initiation and checkpoint response. In yeast, CKII negatively regulates CDK kinase activity thus 
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inhibits DNA replication initiation (Coccetti, Rossi et al. 2004; Tripodi, Zinzalla et al. 2007). 
Also, CKII can phosphorylate human Mcm2 and geminin in vitro (Kulartz, Hiller et al. 2004; 
Montagnoli, Valsasina et al. 2006). However, no physiological implications of these 
phosphorylations have been identified. In addition to the kinases, protein phosphatase 2A has 
been shown to be essential for Cdc45 chromatin loading and DNA replication initiation (Chou, 
Petersen et al. 2002). Together, these findings suggest that many kinases and phosphatases work 
together to regulate cell cycle progression. 
Finding the Sld2 and Sld3 ortholog in higher organisms 
Almost all of the orthologs of replication proteins discovered in yeast have been 
identified and well studied in higher organisms except for Sld2 and Sld3. Unlike many other 
replication proteins, both Sld2 and Sld3 show very low amino acid sequence conservation even 
between the budding yeast and fission yeast Sld2 and Sld3 orthologs. No protein in higher 
organisms has significant sequence homology to the yeast Sld2 and Sld3. However, quite a few 
proteins have been identified in higher organisms showing similar properties as the yeast Sld2 
and Sld3 suggesting that they could be the functional orthologs of these proteins. 
In yeast cells, phosphorylated Sld2 interacts with Dpb11 (budding yeast ortholog of human 
TopBP1). The interaction between Sld2 and Dpb11 is essential for Cdc45 chromatin loading and 
DNA replication initiation. In human cells, RecQ4 is a DNA helicase belonging to the RecQ 
protein family that is essential in repairing damaged DNA (Fan and Luo 2008). In addition to its 
function in DNA damage repair, the N-terminus domain of RecQ4 acquired additional function 
similar to that of the yeast Sld2. Two groups individually showed that RecQ4 is essential for 
DNA replication in Xenopus egg extract (Sangrithi, Bernal et al. 2005; Matsuno, Kumano et al. 
2006). RecQ4 N-terminus domain can bind TopBP1 and is phosphorylated by Cdk2 in vitro. 
Based on these properties, it is hypothesized that RecQ4 could be the higher organism ortholog of 
yeast Sld2. However, depletion of RecQ4 did not block Cdc45 chromatin binding in Xenopus egg 
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extracts. Phosphorylation by CDK is not absolutely necessary for RecQ4 interacting with 
TopBP1. These features are opposite from the yeast Sld2, which calls the conclusion RecQ4 
being the Sld2 ortholog into question. More research is needed to examine the relationship 
between RecQ4 and Sld2 in DNA replication initiation process. 
Yeast Sld3 protein has similar properties as the Sld2. Both proteins are essential targets for 
CDK in the cell. Phosphorylated Sld3 also binds to the Dpb11. After CDK phosphorylation, the 
protein complex of Sld2-Sld3-TopBP1 is essential for Cdc45 chromatin binding. The only 
functional difference between Sld2 and Sld3 is that Sld3 has been shown to interact with Cdc45 
while no interaction between Sld2 and Cdc45 has been reported (Kamimura, Tak et al. 2001; 
Nakajima and Masukata 2002). Three different higher organism Sld3 ortholog candidates have 
been identified recently (Balestrini, Cosentino et al. 2010; Chowdhury, Liu et al. 2010; Kumagai, 
Shevchenko et al. 2010; Sansam, Cruz et al. 2010). Treslin/Ticrr, GEMC1 and DUE-B, all three 
proteins are essential for DNA replication initiation in both human cells and Xenopus egg extract. 
Similar to yeast Sld3, they all interact with both TopBP1 and Cdc45. Both Treslin/Ticrr and 
GEMC1 have been shown to be substrates of CDK in the cell. However, none of these three 
proteins showed strong sequence similarities with the yeast Sld3. In a recent study in fission 
yeast, none of these three protein candidates can individually rescue the DNA replication defect 
caused by an Sld3 temperature sensitive mutant suggesting the function of Sld3 may have rapidly 
evolved into separate tracks in higher organisms (Wang, Kim et al. 2012). Although the 
mechanism by which Sld3-TopBP1-Sld2 loads Cdc45 onto replication origin could be conserved 
from yeast to humans (Labib 2010), the Sld3 function might require the collaboration of different 
proteins in higher organisms.   
DNA replication checkpoint response 
Despite the fact that cells can replicate their genome in high fidelity, living organisms are 
constantly exposed to natural challenges that might cause instabilities to DNA. In order to handle 
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different challenges and ensure the integrity of DNA sequences, cells have evolved a complex 
system called the DNA damage checkpoint response. Checkpoint response detects the 
abnormalities in DNA then activates the repair mechanism to correct the genetic material and 
makes cells more resistant to challenges in order to help cells survive different situations. As a 
result, the checkpoint response is required for cellular viability in DNA damage or replication 
stress conditions.  For example, work in both budding yeast S. cerevisiae and fission yeast S. 
pombe showed that cells are hypersensitive to DNA damage agents and replication challenges 
such as depletion of free dNTPs by hydroxyurea (Kolodner, Putnam et al. 2002). In human, 
mutation of ATM in ataxia telangiectasia patient cells causes the cells to lose the ability to 
suppress DNA synthesis after ionizing radiation, termed radio-resistant DNA synthesis (RDS), 
thus causing cell death afterwards as a result of accumulation of unrepaired DNA damages 
(Painter and Young 1980).  
Different types of DNA damage naturally happen in every organism. Single strand breaks 
(SSBs) is when one of the two strands of DNA is broken, leaving behind a nick or single stranded 
gap on the double stranded DNA. Double strand breaks (DSBs) are that both of the DNA strands 
are broken at the same location, which could be caused by ionizing radiation. Inter-strand 
crosslinks (ICLs), which covalently link the two strands of the double helix, can be induced by 
some cancer chemotherapy drugs including cisplatin (CDDP), mitomycin C (MMC), and nitrogen 
mustards. Modifications such as DNA adducts that covalently bind to DNA, and pyrimidine 
dimers caused by ultraviolet light, are also normal DNA damages and are toxic to cells that are 
exposed to these harmful environmental factors. All the aforementioned DNA damages can 
trigger the DNA damage response, although through different mechanisms.  
The DNA damage response is a signal transduction pathway that is composed of sensors, 
adaptors and effectors. The sensors detect various DNA damage structures, the adaptors transmit 
the signal and effector enzymes trigger the desired physiological outcomes, for example, cell 
cycle arrest. Two PIKKs (phosphoinositide-kinase related family of protein kinases) family 
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protein ATM (ataxia telangiectasia mutated) and ATR (ATM-and Rad3-related) are acting as the 
sensors at the top of the checkpoint signal pathways (Bartek and Lukas 2003; Lavin and Kozlov 
2007). 
ATM was identified as the gene mutated in the inherited disease ataxia telangiectasia 
which is characterized by cerebellar ataxia, extreme sensitivity to radiation and a predisposition to 
cancer (Lavin and Kozlov 2007). In humans, ATM is a 370 kD protein and is detected as dimers 
in unperturbed cells. When DNA double strand breaks happen, MRN (Mre11-Rad50-Nbs1) 
complex is recruited to the damaged site. ATM is then recruited to the MRN complex, where it 
autophosphorylates and is converted from inactive dimer into active monomer (Bakkenist and 
Kastan 2003). Activated ATM will then phosphorylate the effector protein Chk2 in the presence 
of mediator protein 53BP1 and MDC1 (Hurley and Bunz 2007; Shibata, Barton et al. 2010). 
ATR, on the other hand, preferentially detects single strand breaks and stalled replication forks. 
The structure that activates ATR is composed of a stretch of single stranded DNA and a junction 
of single stranded-double stranded DNA (MacDougall, Byun et al. 2007). RPA binding to the 
single stranded DNA is also essential for ATR activation. ATR forms a stable complex with a 
critical partner ATRIP (ATR interacting protein), and is loaded onto RPA coated single stranded 
DNA. But this localization of ATR to single stranded DNA itself is not sufficient to activate the 
checkpoint. 9-1-1 complex (Rad9, Hus1, and Rad1) and TopBP1 are also recruited to the damage 
site and are essential for ATR activation (Lee, Kumagai et al. 2007; Yan and Michael 2009). 
Then ATR is activated by the ATR activation domain on TopBP1. Activated ATR-ATRIP 
complex in turn phosphorylates the effector protein Chk1 with the help of mediator protein 
Claspin (Callegari and Kelly 2007). It was generally believed ATM detects DSB and ATR 
responds to SSB. Recent studies indicated that there is cross talk between the two pathways, for 
example, in many cases the activation of ATM is accompanied by ATR activation (Jazayeri, 
Falck et al. 2006). One of the possible explanations is that one strand of the DNA ends exposed 
by double strand break can be resected by exonuclease, leaving behind another strand as single 
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stranded DNA. RPA is then recruited onto the single stranded DNA and provides structure that 
activates ATR (Adams, Medhurst et al. 2006).  
After DNA damage is detected by the sensors and the signal is transmitted to the effectors, 
the DNA damage checkpoint is activated. Checkpoint induces various cellular responses, among 
which the most obvious effect is inhibition of cell cycle progression. In budding yeast, the G2/M 
checkpoint arrests cell cycle at G2/M phase due to the persistence of securin, a protein factor that 
prevents G2/M phase transition. In an unperturbed cell cycle, securin is ubiquitinated by the 
anaphase promoting complex and degraded at the entry to mitosis. During the DNA damage 
response, securin is stabilized by phosphorylation that blocks its ubiquination (Cohen-Fix and 
Koshland 1997; Agarwal, Tang et al. 2003). The effect of the intra S-phase checkpoint response 
is to inhibit replication origin firing and delay S-phase progression (Paulovich and Hartwell 
1995). Checkpoint response inhibits late origin firing at least partially through inhibiting essential 
replication factors, e.g. Cdc45, from loading onto chromatin (Aparicio, Stout et al. 1999). One 
model to explain this phenomenon is that the activated effector checkpoint kinase phosphorylates 
Cdc25, a phosphatase essential to activate CDK, and thus blocks CDK activation (Furnari, Rhind 
et al. 1997). Other models are through inhibition of DDK activity to prevent Cdc45 loading 
(Costanzo, Shechter et al. 2003; Yanow, Gold et al. 2003).  
There are several proposed functions for the DNA damage response. First, it slows down 
or stalls the cell cycle. This will provide cells sufficient time to repair DNA damages before 
entering S phase, or, in the case of severe damage, to activate programmed cell death. Second, the 
checkpoint response stabilizes replication forks to enable the restart of replication after the 
damage has been repaired. In the absence of checkpoint kinases, stalled replication forks collapse 
and are no longer able to move after removal of the replication challenging agent (Lopes, Cotta-
Ramusino et al. 2001). MCM complex might contribute most to the scenario of fork collapse 
(Tercero, Longhese et al. 2003) since Cdc45 can be reloaded onto the stalled replication fork in S-
phase (Tercero, Labib et al. 2000) but MCM loading is inhibited by high level of CDK and DDK 
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kinase activity (Labib, Tercero et al. 2000). Thirdly, the checkpoint triggers an overall response 
that regulates protein expression levels. Transcription response is able to induce the expression of 
proteins that are involved in DNA repair and dNTP synthesis (Huang, Zhou et al. 1998; Gasch, 
Huang et al. 2001), which could be helpful for repairing the damage. 
DNA Unwinding Element Binding protein, DUE-B 
DUE-B was identified as a novel replication protein that binds to the c-myc DNA 
replication origin. It is a 209 amino acid protein with a highly conserved N-terminal domain that 
shows strong homology to tRNA proofreading enzymes throughout evolution. However, the C-
terminal 60 amino acids are unique to higher organisms and show no significant homology to any 
known proteins (Casper, Kemp et al. 2005). DUE-B is an essential protein in the DNA replication 
pathway. Immunodepletion of DUE-B from Xenopus egg extract inhibits DNA replication while 
siRNA knockdown in human cells delays release from G1 phase (Casper, Kemp et al. 2005). 
DUE-B binds to origins at the transition of G1-S phase and is released from origins shortly after 
DNA replication initiation. In this research, we found that in Xenopus egg extract, chromatin 
binding of DUE-B requires the pre-existence of chromatin bound ORC, MCM and requires CDK 
kinase activity. DUE-B is necessary for chromatin loading of Cdc45 and RPA indicating a 
potential role in activating the MCM complex (Chowdhury, Liu et al. 2010).  
Interestingly, recombinant DUE-B purified from different sources exhibit distinct 
biochemical properties. DUE-B purified from human cells forms a homo dimer and supports 
DNA replication when added into Xenopus egg extract. Recombinant DUE-B from insect cells 
forms a high molecular complex and inhibits DNA replication if incubated in egg extract (Casper, 
Kemp et al. 2005). Structural and biochemical study of DUE-B indicates that recombinant DUE-
B purified from different sources is phosphorylated at different levels. Specifically, DUE-B 
purified from asynchronous HeLa cells shows high level of phosphorylation while the one 
purified from insect cells lacks certain phosphorylation at the C-terminal tail (Kemp, Bae et al. 
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2007).  
In this research, I am able to provide direct evidence that phosphorylation on DUE-B 
changes its activity in binding with other proteins to form the high molecular weight protein 
complexes. Also, I have identified protein phosphatase 2A and Dbf4 dependent kinase as the 
primary regulators controlling DUE-B phosphorylation as well as the high molecular weight 
complexes formation in the cell. Importantly, DUE-B in the high molecular weight complexes 
interacts with the MCM complex in the high molecular weight protein complex. 
Previous research in the lab has shown that DUE-B can be phosphorylated by casein 
kinase II in vitro. Casein kinase II is known to be involved in DNA replication initiation and 
phosphorylates human Mcm2 in vitro (Montagnoli, Valsasina et al. 2006). Now, I provide 
evidence that Casein kinase II phosphorylation can prime DUE-B for DDK kinase activity.  
This research expands the understanding of how DUE-B is regulated during the cell cycle 
especially during the process of DNA replication initiation. Firstly, this research shows that DUE-
B chromatin loading is regulated by multiple mechanisms as other DNA replication proteins. 
During the normal DNA replication process, DUE-B is recruited onto DNA after the pre-RC 
assembly and requires CDK kinase activity. DUE-B chromatin binding is required for Cdc45 
chromatin binding. Additionally, DNA replication checkpoint inhibits DUE-B chromatin loading 
through unknown mechanisms. Secondly, we now know that DUE-B is phosphorylated during 
the S phase of the cell cycle and is dephosphorylated in the M phase of the cell cycle. The high 
molecular weight protein complex forms in vitro and in vivo when DUE-B phosphorylation level 
is low. Potentially, DUE-B interacts with the MCM complex to inhibit its activity during the M 
phase of the cell cycle. Last but not the least, phosphorylation at the DUE-B C-terminus domain 
controls DUE-B activity in DNA replication, cell survival and DUE-B subcellular localization. 
Details about these findings will be discussed in the following chapters.  
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MATERIALS AND METHODS 
Preparation of Xenopus egg extracts 
Female frogs were primed with 50-100 units/frog of pregnant mare serum gonadotropin 
(PMSG, Sigma G4877) 3-7 days before eggs were required. Approximately 20 hours before eggs 
were to be collected, primed frogs were injected with 300-800 units/frog of human chorionic 
gonadotropin (HCG, Sigma CG10). Frogs injected with HCG were separated into individual 
containers containing 5 liters of high salt barth solution (110 mM NaCl, 15 mM Tris pH 7.6, 2 
mM KCl, 1 mM MgCl2). Frogs should not be fed after placed in the high salt barth solution. Eggs 
laid by different frogs were harvested 20 hours after HCG injection in 150 mL beakers separately 
and transported to the lab protected from dramatic change of water temperature to prevent egg 
self activation. Any batch that contains more than 5 percent bad white eggs should be rejected 
immediately.  Eggs collected were incubated with fresh made de-jelly solution (2.2% cysteine 
monohydrate HCl, pH 7.8, 1 mM EGTA) for 10 minutes with gently mixing. Eggs were then 
washed three times in room temperature Barth solution (88 mM NaCl, 2 mM KCl, 1 mM MgCl2, 
15 mM Tris, pH 7.4, 0.5 mM CaCl2). If many eggs break during washes, that batch of eggs 
should be rejected. Small amount of bad eggs featured as white in color were removed during the 
washes using Pasteur pipette. Good eggs were combined into one beaker and activated by adding 
the calcium ionophore A23187 (2 µg/ml) to the eggs in ~50 ml of Barth solution. After 10 
minutes incubation the eggs were washed three times with Barth solution, then 4-5 times in cold 
Extraction Buffer (50 mM KCl, 50 mM HEPES-KOH, pH 7.6, 5 mM MgCl2, 2 mM DTT). Eggs 
were subsequently transferred to an appropriately sized tube and centrifuged at 800 x g for 1 
minute at 4°C to pack the eggs in the tube. Excess buffer and bad eggs on top of the tube were 
removed. 10 µg/ml cytochalasin B, 1 mM DTT and 10 µg/ml each final concentration of pepstatin 
A, leupeptin, aprotinin were supplemented in the tube. Then the tubes were centrifuged in a 
swinging bucket rotor at 16,000 x g for 10 minutes to spin-crush the eggs. Eggs were fractionated 
14	  
into a grey insoluble pellet, a brownish cytoplasmic layer, and a yellow lipid layer (Appendix 1). 
The cytoplasm was removed by inserting a needle into the side of the tube and withdrawing the 
cytoplasmic extract with a syringe. The extract was then transferred to a new tube and diluted 
15% (by volume) with Extract Dilution Buffer (50 mM KCl, 50 mM HEPES-KOH, pH 7.6, 0.4 
mM MgCl2, 0.4 mM EGTA, 10% sucrose). The extract was then centrifuged twice at 48,500 x g 
for 20 minutes at 4°C. This spin gives a small black insoluble pellet, a small clear gelatinous 
protein/ribosome layer, a larger loose brown membranous layer, a clear golden cytoplasmic layer, 
a layer of white membranous material, and a small yellow lipid plug. The golden cytoplasmic 
layer and white membranous layer on top were removed as described above, supplemented with 
glycerol to 1%, and frozen as 100 µl aliquots in liquid nitrogen. These low speed supernatant 
(LSS) extracts were finally stored at – 80 °C until ready for use. 
Preparation of demembranated Xenopus sperm chromatin 
Three male frogs were primed with 100 units/frog of HCG 2-7 days before preparation. 
Frogs were anaesthetized and euthanized using 5% benzocaine. The abdominal wall was cut open 
using a small surgical scissors. The testes were identified as two white to yellow color bean 
shaped organs that measure about 1 cm long next to the spine. Testes were carefully removed 
from the frog free of fat bodies or blood vessels. Testes from different frogs were combined and 
submerged in extraction buffer (50 mM KCl, 50 mM HEPES-KOH, pH 7.6, 5 mM MgCl2, 2 mM 
DTT). Testes were minced using a single edge razor blade and then homogenized thoroughly 
using a small Dounce homogenizer (Pestle B). Homogenized tissue was transferred to an 
appropriate tube and centrifuged at 100 x g for 50 seconds to remove the large pieces of tissue. 
Supernatant was collected and spun at 2000 x g for 5 minutes at 4 °C. Precipitated frog sperms 
were re-suspended in 2 mL SuNaSp buffer (250 mM sucrose, 75 mM NaCl, 150 µM spermine-
tetra-hydrochloride, 500 µM spermidine- tri-hydrochloride) at room temperature. 100 µL 2 
mg/mL lysolecithin was added into re-suspended sperms and incubated for 5 minutes. A small 
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aliqout of sperm suspension incubated with lysolecithin was stained with 1 ug/mL Hoechst 33258 
and examined immediately under florescent microscope with FITC channel. More lysolecithin 
was added and incubated with sperm suspension until more than 95% of nuclei were dye 
permeable. 300 µL 30% bovine serum albumin in SuNaSp was added to quench the lysolecithin. 
Sperm chromatin was pelleted by centrifugation at 2000 x g for 5 minutes at 4 °C. The sperm 
chromatin pellet was resuspended in 500 µL extraction buffer supplemented with 30% glycerol. 
Sperm chromatin was stored in -80 °C until ready for use.   
Chromatin binding of DNA replication factors 
Xenopus egg extract prepared as described above was thawed on ice and supplemented with 
250 ug/ml final concentration of cycloheximide, 3 ug/ml final (1X) concentration of nocodazole, 
protease inhibitor mix (3 µg/ml each final concentration of pepstatin A, leupeptin, aprotinin) and 
ATP regeneration system (50 µM final concentration of phosphocreatine, 2 µM final 
concentration of ATP, 5 ug/ml final concentration of CPK). Sperm chromatin was added into the 
G1 phase egg extract to the final concentration of 2000 sperms/µL. Reactions were incubated at 
room temperature for desired time. Reactions were then stopped by addition of a 10-fold volume 
of ice-cold buffer XB (10 mM HEPES, pH 7.6, 100 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2, 5% 
sucrose, 1 mM DTT, protease inhibitors) containing 0.6% Triton X-100 and pipetted up and 
down for 3 times. Diluted reaction was carefully layered over 1 mL buffer XB containing 0.7 M 
sucrose cushion and centrifuged in a swinging bucket rotor at 3000 x g for 3 minutes at 4°C. The 
chromatin pellets were washed once in l mL buffer XB and recentrifuged. Chromatin pellets were 
boiled in 6 x SDS-PAGE sample buffer and separated by SDS-PAGE then analyzed by Western 
blotting. 
The chromatin spin down assay utilized the sucrose cushion to isolate the chromatin bound 
protein from free proteins in the egg extract. Protein aggregation in Xenopus egg extract would 
result in background signal for some proteins on Western blot independent of sperm chromatin. 
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Pioneer experiments should be carried out to determine the optimum nocodazole concentration 
and centrifugation speed for each batch of Xenopus egg extract. Appendix 2 is an example of 
condition optimization experiment showing that in this particular batch of egg extract, 4 X 
nocodazole and 2000 x g centrifugation are able to minimize the background signal.  
Immunodepletion of protein from Xenopus egg extracts 
To deplete proteins from Xenopus egg extracts, antibodies against the protein to be depleted 
were incubated with Protein G agarose beads in 4 °C for 2 hours. After several washes with ELB 
to remove any unbound antibody, the antibody-bound beads were incubated with egg extract for a 
period of 20-30 minutes at 4°C. The beads were then pelleted by microcentrifugation (2000 rpm, 
2 min, 4°C) and the supernatant transferred to a new tube containing fresh antibody-bound 
agarose beads and the process repeated. Typically 3 rounds of immunodepletion were required to 
deplete xDUE-B and xOrc2 by greater than 99% from the extract. Care should be taken to avoid 
diluting the egg extract by the buffer carried over with the protein G agarose. All the egg extract 
handling processes were carried out rapidly and kept on ice all the time to maintain the activity of 
egg extract. ATP regenerating system was not added to the egg extract until sperm chromatin was 
ready to be added.  
DNA replication assay using agarose gel electrophoresis 
To monitor DNA synthesis in Xenopus egg extracts, G1 phase egg extract was 
supplemented with α-[32P]-dCTP (0.1 µCi/µl) and sperm chromatin was added to a final 
concentration of 2,000 sperms/µl of extract. Reactions (5 µl) were incubated for 30 to 120 
minutes at room temperature before stopping with 10 µl of Stop buffer (8 mM EDTA, 0.13% 
phosphoric acid, 10% Ficoll, 5% SDS, 0.2% bromophenol blue, 80 mM Tris, pH 8). After all the 
time points were collected, proteinase K (40 µg) was added to each sample and then incubated at 
37 °C for 1 hour. Samples were then loaded directly into wells of a 0.8 % 1X TBE agarose gel 
and electrophoresed until the bromophenol blue traveled for at least 1 inch out of the well. The 
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gel was excised right above the bromophenol blue and was subsequently dried and exposed to 
film in -80 °C. 
Construction of plasmids 
Human DUE-B was cloned into multiple plasmids for different purpose. To express DUE-
B in E.coli, DUE-B was cloned into pTricHis (Invitrogen) backbone with BamH I and Hind III. 
To express DUE-B in HeLa cells, DUE-B was cloned into pcDNA3.1 (Invitrogen) backbone with 
Bam HI and Age I. To tag DUE-B with YFP, DUE-B was cloned into pEYFP N1 (Clontech) 
backbone with Bgl II and Xho I. To express DUE-B in vitro, DUE-B was cloned into pT7CFE-
His (Thermo Scientific) backbone with Bam HI and Xho I.  
Site directed mutagenesis  
To modify DUE-B amino acid sequence, different mutations were generated using the site 
directed mutagenesis method adapted from Dr. Yongjie Xu. Wild type DUE-B was cloned into an 
expression vector and was used as PCR template for all the mutations.  
To mutate, delete or add up to three continuous amino acids, a pair of overlapping regular 
PCR primers was designed as shown in Appendix 3A. Generally, the overlapping region of 
primers would contain target DNA sequence in the middle flanked by 5-10 nucleotides that match 
the template on each side. Besides the overlapping region, each primer should have 6-11 
nucleotides 3’ overhang ending with C or G. The WT DUE-B template was amplified using these 
primers by Phusion High-Fidelity DNA Polymerase (NEB M0530S) for 20 rounds. The PCR 
product was digested by 1uL Dpn I at 37 °C for 1 hour to remove template WT DUE-B plasmids. 
100-200 µL ultra-competent cells (will discuss later) were transformed with 10-20 µL Dpn I 
treated PCR reaction by heat shock at 42 °C for 90 seconds. Heat shocked cells were 
supplemented with 1 mL drug free LB medium and recovered at 37 °C for 1 hour then plated 
onto LB plate with selectable antibiotics.  
To mutate, delete or add more than 3 continuous amino acids, a pair of 5’ phosphorylated 
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PCR primers was designed as shown in Appendix 3B. Generally, the 5’ region of each primer 
would contain half of the target sequence that does not match the template. The 3’ region 
consisted of 15-20 nucleotides sequence that matches the template. The WT DUE-B template was 
amplified using these primers by Phusion High-Fidelity DNA Polymerase (NEB M0530S) for 20 
rounds. The PCR product was purified using cycle pure kit and then ligated with T4 DNA ligase 
at room temperature for 2 hours. The ligase was heat inactivated at 65°C for 10 minutes and then 
digested by 1uL Dpn I at 37 °C for 1 hour to remove template WT DUE-B plasmids. 5 µL Dpn I 
digested product was transformed with 100-200 µL regular competent cells. 
Preparation of ultra-competent cells 
E.coli strain such as DH5α was streaked out on LB plate without any selective marker. 
Single colony was grown into 10 mL start culture in LB medium without antibiotic at 37 °C 
overnight. The start culture was inoculated into 250 mL antibiotic free LB medium and grown at 
18 °C overnight. Cell culture was chilled on ice water for 10 minutes when OD600 reached 0.55. 
Cells were spun down at 4000 x g 4 °C for 10 minutes. LB supernatant was removed completely 
and the pellet was resuspended in 75 mL of ice-cold sterile Inoue Transformation buffer (55 mM 
MnCl2, 15 mM CaCl2, 250 mM KCl, 10 mM PIPES/KOH, pH 6.7). Cells were spun down again 
at 4000 x g 4 °C for 10 minutes. Pellet was resuspended gently in 20 µL ice-cold sterile Inoue 
Transformation buffer. Cell suspension was supplemented with 1.5 mL sterile DMSO and 
incubated on ice for 10 minutes. The cell suspension was separated into 200 µL aliquots and 
stored in -80 °C until ready for use. 
Protein purification  
Different proteins were expressed in different E.coli strains. DUE-B was cloned into 
pTrcHis plasmid and transformed into E.coli strain BL21. Cells were cultured in 37 °C until 
OD600 reached 0.6-0.8. Protein expression was induced by adding 1 mM IPTG into cell culture at 
37 °C for 5 hours. Cdc45 and human TopBP1 was expressed in E.coli strain BL21 Rosetta 2. 
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Cells were cultured in 37 °C until OD600 reached 0.8-1.0. Cell culture was chilled on ice for 10 
minutes before adding IPTG. Protein expression was induced by adding 0.5-1 mM IPTG at 18 °C 
for 6 hours. After IPTG induction, cells were spun down at 4000 x g 4 °C for 10 minutes. Pellet 
was resuspended in QIA lysis buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM 
imidazole, 1mM PMSF) and sonicated on ice. Cell lysate was centrifuged at 20,000 x g 4 °C for 
10 minutes then the cleared supernatant was rotated with Qiagen Ni-NTA agarose for 4 hours in 4 
°C. Agarose was pelleted at 4000 x g 4 °C for 2 minutes then washed 5 times with QIA wash 
buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM PMSF). Protein was 
eluted using the QIA elution buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 250 mM imidazole 
1 mM PMSF). High purity DUE-B was eluted using an imidazole gradient from 50 mM to 500 
mM made from QIA elution buffer. Protein was then dialysised against egg extract Extraction 
Buffer (50 mM KCl, 50 mM HEPES-KOH, pH 7.6, 5 mM MgCl2, 2 mM DTT).  
Antibody affinity purification 
Five mg purified DUE-B was separated by a 1.5 mM 12% SDS PAGE gel. The gel was 
transferred to a nitrocellulose membrane at 0.9 A for 1 hour. Membrane was stained with 
Ponceau S and the DUE-B band was excised out to minimize the amount of contaminating 
protein co-purified with recombinant DUE-B. Ponceau S staining was washed off by rinsing three 
times with TBST (20 mM Tris, pH 7.6, 136 mM NaCl, 0.3% Tween-20). The membrane carrying 
DUE-B was blocked twice with blocking solution (3% BSA in TBST) for 1 hour at room 
temperature. Membrane was removed from blocking solution and then incubated with 15 mL 
WRSU7 rabbit anti-DUE-B serum for 2 hours at room temperature. Membrane was washed three 
times with TBST for 20 minutes at 4 °C. Washed membrane was rinsed twice with TBS (20 mM 
Tris, pH 7.6, 136 mM NaCl) then was cut into small pieces in TBS. Membrane slices were 
transferred to a 2 mL eppendorf tube and then quickly rinsed one more time with water. 
Membrane bound antibody was eluted 4 times with 0.25 mL fresh prepared glycine solution (100 
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mM glycine, pH 2.0) for 1 minute each time at 4 °C. The glycine solution was recovered and 
quickly neutralized by 1/10 volume of 1 M Tris, pH 8.0. Then the eluent was supplemented with 
equal volume of glycerol and stored at -20 °C.  
Protein kinase assay 
500 ng recombinant DUE-B purified from HeLa cells or E.coli cells were incubated with 
200 units of commercial Cdk2 (NEB P6025) in 1 X Cdk2 reaction buffer (50 mM Tris-HCl, pH 
7.5, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01 % Brij 35) at 30 °C for 2 hours. Reaction was 
supplemented with 200 µM ATP and 300 µCi/µmol ϒ-[32P]-ATP. Reaction was stopped by 
adding equal volume of SDS sample buffer and boiled at 95 °C for 5 minutes. Samples were 
separated by SDS PAGE and the gel was dried then exposed to X-ray film at -80 °C.  
Size-exclusion chromatography 
Sephacryl S 400 HR (GE Life Science 17-0609-10) resin was diluted in modified egg 
extract extraction buffer (50 mM KCl, 50 mM HEPES-KOH, pH 7.6, 5 mM MgCl2) and then de-
aerated by attaching to a vacuum for 20 minutes. The resin was slowly filled into a 20 mL column 
and allowed to settle for 1 week. The column was equilibrated by running de-aerated extraction 
buffer through the column for 3 hours. Then the column was attached to the ÄKTA FPLC system 
kindly provided by Dr. Yongjie Xu. Gel filtration column was then equilibrated using the FPLC 
system with extraction buffer at a flow speed of 0.1 mL/min for 4 hours. 100 µL protein sample 
was loaded using a syringe through a micro loading loop on the FPLC system. Proteins were 
fractionated by size at a flow speed of 0.1 mL/min and the fractions were collected at 400 
µL/fraction using the fractionator in the FPLC system. Column was calibrated using protein 
standard containing thyroglobulin (670 kD), alcohol dehydrogenase (150 kD), bovine serum 
albumin (66 kD) and cytochrome C (12.4 kD). Different samples were fractionated at the exact 
same conditions as the protein standards.  
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Western blotting  
Protein expression in cell lysates and egg extracts was determined by SDS-PAGE and 
Western blot analysis. Anti-human actin, anti-FLAG and anti-human/Xenopus Mcm7 antibodies 
were purchased from Sigma. Both WRSU1 and WRSU7, rabbit anti-DUE-B antibodies were 
raised in rabbits against a 6xHis-tagged recombinant human DUE-B expressed in bacteria. 
WRSU4, rabbit anti-xOrc2 antibody was raised in rabbits against baculovirus-expressed 
recombinant xOrc2. Both the WRSU1 and WRSU4 antibodies have been previously described 
(Casper 2004). WRSU5, rabbit anti-human TopBP1 antibody was raised in rabbits against E.coli 
expressed recombinant human TopBP1 by Casey Wells. All WRSU1, 4, 5, 7 antibodies can 
recognize proteins from both human and Xenopus laevis. Anti-RPA70, anti-GFP was purchased 
from Santa Cruz Biotechnology. Anti-human Cdc45, anti-human TopBP1 antibodies were 
purchased from Bethyl Laboratories. Rabbit anti-ORC1 antibody was generously provided by Dr. 
Chikashi Obuse (Kyoto University). Anti-PCNA antibody was from Thermo Scientific. Anti-6 X 
His, anti-Mcm2, anti-Mcm3, anti-Mcm5, anti- phosphoserine/threonine antibodies were 
purchased from Abcam. Anti-Chk1 phosphorylated Ser 345 antibody was purchased from Cell 
Signaling. Antibodies against the Xenopus proteins TopBP1, Cdc45 were provided by Dr. Matt 
Michael (Harvard University) and Dr. Johannes Walter (Harvard University) respectively. 
Immunoprecipitation and co-immunoprecipitation 
To study protein-protein interactions, co-immunoprecipitation experiments (co-IP) were 
carried out using specific antibody conjugated protein G beads. Three µL of protein G beads 
slurry/sample were washed with JY IP buffer (20 mM Hepes, pH 7.4; 0.5 % Triton X-100; 150 
mM NaCl; 1.5 mM MgCl; 2 mM EGTA; 10 mM NaF; 2 mM DTT; 1 mM NaVO4; 1 mM PMSF; 
20 µM aprotinin). Specific antibody was incubated with protein G beads at 4 °C for 2 hours then 
washed with JY IP buffer twice to remove any unbound antibody. The antibody-conjugated beads 
were incubated with clear protein lysate from human cell or Xenopus egg extract at 4 °C for 4 
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hours on a rotator. The beads were washed 5 times with wash buffer (modified JY IP buffer, 
RIPA, modified egg extract extraction buffer or TBST). Then the bead bound proteins were 
dissolved in SDS sample buffer and then subjected to SDS PAGE and Western blotting. If the 
target protein of interest is around 25 kD or 50 kD, no reducing agent such as beta 
mercaptoethanol should be included in the SDS sample buffer to avoid the signal from IgG light 
chain or heavy chain respectively. On the contrary, if the target protein of interest is above 75 kD, 
reducing agent should always be included to eliminate interfering signal from IgG whole protein. 
Cell culture and Cell transfection 
HeLa cells were maintained as adherent cultures in DMEM containing 10% newborn calf 
serum. Human fibroblast cells were kept in 10% fetal bovine serum. To create stable cell lines 
expressing DUE-B, cells transfected with pcDNA3.1 plasmids carrying DUE-B were subjected to 
400 ug/ml effective G418 selection for 2 weeks. To synchronize cells in mitotic phase, cells were 
incubated in complete medium supplemented with 50 ng/mL nocodazole (Sigma) for 24 hours. 
Nocodazole should be prepared within a month prior using to avoid adverse effect on cell 
survival and ensure releasing from M phase. 
Transfection of plasmid DNA employed Lipofectamine 2000 (Invitrogen), the amount of 
DNA used exactly as recommended by the manufacturer, however, the amount of Lipofectamine 
2000 was reduced to half to minimize the cell death after transfection. For siRNA transfection, 
the amount of siRNA used was optimized by using the BLOCK-iT Fluorescent Oligo (Invitrogen) 
as shown in Appendix 5.  
Flow cytometry  
To analyze the cell cycle progression, DNA in cells was stained and measured by flow 
cytometry. The minimum size of tissue culture used for a single flow sample should be at least 
200,000 cells. Adhering cells such as HeLa cells were washed with PBS and trypsinized from 
plate. PBS wash and the trypsinized cells were pooled and pelleted by centrifugation at 500 x g 
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room temperature for 5 minutes. Cell pellet was washed once with PBS followed by another spin 
at 500 x g at room temperature for 5 minutes. Cells pellet was completely suspended in 1 mL ice-
cold 70% ethanol and fixed at -20 °C for at least 20 minutes. Fixed cells were pelleted at room 
temperature using the same centrifugation condition above then washed once with PBS. Cells 
were resuspended in 1 mL PBS supplemented with 1 µL 29mg/mL RNase A (Sigma). Cells were 
incubated at 37 °C for 1 hour. Cell suspension was incubated with 50 ug/mL propidium iodide 
PBS solution at 4 °C for 30 minutes. Stained cells were directly analyzed using the BD Accuri C6 
flow cytometer under the FL2-A channel. Flow cytometry data was analyzed using the FCS 
Express 4 software. 
Fluorescence microscopy 
Cells expressing YFP tagged DUE-B were fixed on tissue culture plate by 2% 
paraformaldehyde made in PBS. Cells were then permeabilized with 0.5% Triton X-100 solution 
for 10 minutes. Triton was washed off by PBS and then the cover glass was mounted onto the 
tissue culture plates using VECTASHIELD Mounting Medium with DAPI. Cells were visualized 
using Leica inverted microscope system kindly provided by Dr. Madhavi Kadakia. 
Colony forming assay 
 Cells were plated into 6 well plates with 70% confluence 16 hours prior to transfection. 
Cells were transfected with exact same amount of pcDNA3.1 plasmids containing wild type 
DUE-B or DUE-B mutants. 24 hours after transfection, cells were washed with PBS and 
trypsinized from plate as described in preparing flow cytometry samples. Approximately, 2,000 
cells/well were plated into a new 6 well plate for each sample. Cells were grown in the new plate 
containing 400 ug/ml effective G418 for 2 weeks. Cell culture media was changed every 2 days. 
After 2 weeks, cells were washed with PBS and then stained with 1 mL 0.1% crystal violet at 
room temperature for 5 minutes. The excessive stain was removed by washing plate with water. 
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RESULTS  
I. DUE-B is recruited onto replication origin after pre-RC formation 
Sequential binding of replication proteins onto chromatin during replication initiation 
DNA replication proteins bind to chromatin in a strictly defined order to ensure the 
chromosome is duplicated once and only once every cell cycle. Data from previous research in 
our lab indicated that DUE-B is an essential protein involved in replication initiation (Casper, 
Kemp et al. 2005). DUE-B binds to chromatin in an Orc2 dependent manner. A hypomorphic 
HCT116 cell line expressing a low level of a truncated form of Orc2 (Orc2 Δ /-) had significantly 
less amount of chromatin bound DUE-B. Moreover, knocking down DUE-B from HeLa cells 
using siRNA dramatically decreased the amount of Cdc45 and RPA bound to chromatin 
(Chowdhury, Liu et al. 2010). These results indicate that DUE-B is a replication factor that is 
recruited onto chromatin after the origin recognition complex but before Cdc45 and RPA.  
To further understand the timing of DUE-B chromatin binding relative to other replication 
factors during the replication initiation process, a semi in vitro system using egg extract prepared 
from African clawed frog Xenopus laevis was introduced in the following research. Xenopus egg 
extract system has been shown to mimic the initiation of replication, DNA checkpoint responses 
and DNA repair pathways observed in vivo. As a result, it is used as a powerful tool to investigate 
the DNA replication initiation, DNA damage checkpoint response and other cellular event in 
higher organisms. Egg extract prepared from G1 phase eggs has a high concentration of 
replication proteins and is ready to replicate many exogenous DNA templates added into the 
reaction in a short time frame of 1-3 hours (Walter, Sun et al. 1998). After adding the natural 
DNA template, the membrane free sperm chromatin, into G1 phase egg extract, DNA replication 
factors started to bind onto chromatin in specific order as example in Figure 1A. Chromatin 
bound Orc1 was readily detectable 10 minutes after DNA templates were incubated with egg 
extract. The fact that Orc1 binds to the chromatin before every other known replication proteins 
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reflects that ORC is the first part of replication machinery that recognizes replication origins and 
serves as a platform to recruit other proteins onto chromatin. Mcm7 as a subunit of the Mcm2-7 
complex appeared on the chromatin in an ORC dependent manner in agreement with the model 
that MCM complex is recruited onto replication origins marked by ORC with the help of Cdc6 
and Cdt1 (Bell and Dutta 2002). Cdc45 was loaded on to the MCM to activate its helicase activity 
after CDK and DDK were activated. As a result, RPA32 was detected almost the same time when 
Cdc45 was loaded onto chromatin as an indication of double stranded DNA unwinding. The 
BRCT domain containing protein TopBP1 carries out important roles in both DNA replication 
and checkpoint activation. Since the role of TopBP1 in DNA replication initiation is to load 
Cdc45 (Van Hatten, Tutter et al. 2002), the majority of TopBP1 was recruited at the same time as 
Cdc45. On the other hand, the finding that a fraction of TopBP1 was loaded after ORC binding is 
also consistent with other additional reports that TopBP1 showed CDK dependent and 
independent chromatin loading in Xenopus egg extracts (Hashimoto and Takisawa 2003). 
The result in Figure 1A suggests that the Xenopus egg extract system used in this study is 
able to faithfully represent the sequential loading of replication factors onto replicating 
chromatin. Interestingly, DUE-B signal was detected almost the same time as Cdc45, arguing that 
DUE-B gets loaded onto the chromatin after MCM complex and could be involved in the pre-
initiation complex (pre-IC) formation. Indeed, results from other lab members showed DUE-B 
interacts with Cdc45 and TopBP1 in both human cells and Xenopus egg extract (Chowdhury, Liu 
et al. 2010). In order to understand the dynamics of DUE-B binding onto the chromatin, a 
prolonged incubation of sperm chromatin with egg extract was carried out with the same setup as 
in Figure 1A. As shown in Figure 1B, Cdc45 was loaded onto chromatin after Mcm7. The level 
of chromatin bound Cdc45, Mcm7 and TopBP1 stayed the same after binding to chromatin while 
DUE-B only transiently bound to chromatin. This phenomenon suggests DUE-B might perform 
an enzymatic function in the process of replication factors chromatin loading.  
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Figure 1. DUE-B binds to chromatin at the same time as Cdc45 and is released after 
replication initiation.  
(A) Sperm chromatin was incubated in G1 phase Xenopus egg extract in a final concentration of 
2000 sperms/µL at room temperature for indicated time. After incubation, chromatin bound 
proteins were isolated by passing sperm chromatin through 0.7 M sucrose cushion. Pellets were 
boiled in SDS sample buffer and then subjected to SDS PAGE. Proteins were transferred to 
PVDF membrane and detected using specific antibody. Egg extract (xtr), 1 µL G1 phase egg 
extract as positive control; Negative control (-), no sperm chromatin added. 
(B) Sperm chromatin was incubated in G1 phase Xenopus egg extract as described in A for longer 
time. Chromatin bound proteins were isolated and detected using specific antibodies. 
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DUE-B binding to chromatin requires pre-RC formation and s-phase CDK activity 
Previous research has shown that DUE-B binding to chromatin depends on ORC, however 
there is not enough information about where DUE-B locates in the replication pathway. As shown 
in Figure 1, DUE-B binds to chromatin after Mcm2-7 complex but it is not know if DUE-B 
binding to chromatin requires MCM. To answer this question, recombinant geminin was added 
into G1 phase egg extract to block MCM binding onto chromatin (Lutzmann, Maiorano et al. 
2006).  Consequently, replication factors that require MCM will not bind to chromatin in the 
presence of excessive geminin. As expected, adding geminin to extract prevented Cdc45 binding 
to chromatin (Figure 2, lanes 8-11). On the other hand, Orc1 loading was not affected by the 
geminin treatment which agrees with the fact that ORC complex is epistatic to MCM in the 
replication initiation process. Interestingly, compared to the untreated control (Figure 2, lanes 2-
5), DUE-B chromatin binding was completely inhibited in the presence of geminin (Figure 2, 
lanes 8-11). This phenomenon suggests that DUE-B binding onto replication origin depends on 
the Mcm2-7 complex. Therefore, DUE-B binds to chromatin after pre-replication complex 
assembly. 
Loading of MCM onto the chromatin is the last step of the pre-replication complex 
assembly, in which the MCM does not have helicase activity yet. During the transition of G1 to S 
phase due to increasing kinase activity of CDK and DDK, more replication proteins are loaded 
onto the pre-RC to activate MCM. In this process in yeast, S-phase CDKs phosphorylate Sld2 and 
Sld3 to bring Cdc45 onto MCM complex (Zegerman and Diffley 2007). Given the fact that DUE-
B binds to chromatin at almost the same time as Cdc45, it is possible that DUE-B loads onto 
chromatin through the same mechanism as Cdc45 and is a result of CDK/DDK kinase activity. To 
test this hypothesis, a selective cyclin dependent kinase inhibitor, roscovitine, was introduced into 
the egg extract. Roscovitine is a 2,6,9-substituted purine analog, which specifically binds to the 
CDKs at the ATP binding pocket and thus inhibits the kinase activity (Noble, Endicott et al. 
2004; Bach, Knockaert et al. 2005). By incubating Xenopus egg extract with roscovitine before  
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Figure 2. DUE-B binding to chromatin is inhibited by geminin.  
Xenopus egg extract was incubated with or without 250 nM recombinant geminin for 10 minutes 
before adding sperm chromatin. Chromatin bound proteins were isolated at indicated time points 
then analyzed by Western blot as described in Figure 1. Egg extract without sperm chromatin is 
used as negative control (lane 6). 1 ul egg extract was loaded in the positive control lanes (lane 1 
and 7). Egg extract (xtr), 1 µL G1 phase egg extract as positive control; Negative control (-), no 
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Figure 3. DUE-B, Cdc45, TopBP1 and Mcm7 binding to chromatin is inhibited by 
roscovitine  
Roscovitine was incubated with G1 phase Xenopus egg extract 10 minutes before adding sperm 
chromatin at room temperature. Sperm chromatin was added into roscovitine treated or untreated 
egg extract to the final concentration of 2000 sperm/ul. After incubating with egg extract at room 
temperature, sperm chromatin was then isolated at indicated time points and the chromatin bound 
proteins were analyzed by Western blot. Egg extract (xtr), 1 µL G1 phase egg extract as positive 
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adding DNA template, chromatin binding of Cdc45 and TopBP1 are greatly inhibited comparing 
to the control (Figure 3). At the same time, DUE-B chromatin binding is abolished. This result 
agrees with the finding by Asif Chowdhury that inhibition of Cdk2 by the CDK inhibitor p27 in 
Xenopus egg extract inhibits DUE-B as well as Cdc45 binding onto chromatin (Chowdhury, Liu 
et al. 2010), which indicates that Cdk2 kinase activity is essential for DUE-B recruitment onto 
replication origin.  
However, it is surprising to notice that the chromatin bound Mcm7 also decreased under the 
treatment of roscovitine while the p27 does not affect the MCM level. It is possible that 
roscovitine has a broad spectrum of inhibiting CDKs kinases activity that it inhibits both S-phase 
CDKs and CDKs activates during other phase of the cell cycle (Bach, Knockaert et al. 2005). 
Interestingly, the phosphorylation of Mcm3 by Cdk1 in G1 phase is reported to be important for 
MCM complex formation during replication initiation (Lin, Aggarwal et al. 2008). 
DUE-B is necessary for Cdc45 and TopBP1 chromatin binding 
Although the orthologs of Sld2 and Sld3 in higher organisms are still under investigation, 
there is good evidence showing that the mechanism of how Cdk2 regulates replication initiation is 
conserved throughout evolution (Boos, Sanchez-Pulido et al. 2011; Kumagai, Shevchenko et al. 
2011). The major role of Cdk2 in yeast is to phosphorylate Sld2 and Sld3 to recruit Cdc45 onto 
the MCM complex (Zegerman and Diffley 2007). Since DUE-B and Cdc45 load onto chromatin 
at almost the same time (Figure 1 and Figure 2), and both DUE-B and Cdc45 loading requires 
Cdk2 kinase activity, we asked whether or not DUE-B loading onto chromatin affects Cdc45 
chromatin binding. To answer this question, endogenous Xenopus DUE-B or Orc2 was depleted 
from G1 phase egg extract using DUE-B specific antiserum WRSU1 or Orc2 specific antiserum 
WRSU4 separately. After 3 rounds of depletion, the concentration of endogenous DUE-B or Orc2 
had been decreased to an undetectable level while the other replication proteins were not affected 
(Figure 4). Sperm chromatin was incubated in these differently depleted egg extracts.              
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Figure 4. DUE-B depletion inhibits Cdc45 loading onto chromatin.  
DUE-B or Orc2 was individually immunodepleted from Xenopus egg extract before sperm 
chromatin was added into egg extract. Sperm chromatin was added into egg extract to the final 
concentration of 2000 sperm/ul. After incubating with egg extract at room temperature, sperm 
chromatin was then isolated at indicated time points and the chromatin bound proteins were 
analyzed by Western blot. Positive controls: (ΔMock) 1 ul mock depleted egg extract; (ΔDUE-B) 






As expected, Orc2 depletion inhibited the chromatin binding of every downstream replication 
protein such as Mcm7, Cdc45, TopBP1 and DUE-B compared to the mock-depleted samples 
(lanes 7-9). This result again validated the fact ORC binding to chromatin is the first step of 
replication initiation. Notice that minimal amounts of Mcm7, Cdc45 and TopBP1 start to be 
detectable after 60 minutes incubation. This could result from the remaining Orc2 left in egg 
extract that was still active in spite of very low concentration. On the other hand, in DUE-B 
depleted samples the Orc2 or Mcm7 chromatin binding pattern did not change which agrees with 
previous finding that DUE-B binds to chromatin after pre-RC formation. Interestingly, the 
chromatin binding of Cdc45 and TopBP1 was dramatically delayed when DUE-B was depleted 
(lanes 4-6). Similar to the situation in Orc2 depleted samples, the remaining DUE-B in egg 
extract was still able to carry out its function, however the reaction speed would be slower at 
lower concentration according to the rate law in chemical kinetics. This result indicates that 
Cdc45 and TopBP1 chromatin binding depends on DUE-B loading onto chromatin. Importantly, 
previous research in HeLa cells found that DUE-B depletion using siRNA decreased the 
chromatin bound Cdc45 and RPA (Chowdhury, Liu et al. 2010). Altogether, these results suggest 
that DUE-B is a conserved replication factor that acts after MCM and before Cdc45 and TopBP1 
in higher organisms. 
The DNA replication mechanisms obtained from yeast studies have proven to be highly 
conserved in vertebrates (Sclafani and Holzen 2007), which suggests that Sld2 and Sld3 activates 
after MCM and regulate Cdc45 and TopBP1 chromatin loading. Although the identity of the 
higher organism Sld3 ortholog is still under investigation, it has suggested that the protein factor 
regulating Cdc45 and TopBP1 chromatin loading would share some properties with yeast Sld3 
(Labib 2010). Similar to Sld3, DUE-B binds both Cdc45 and TopBP1 in asynchronous HeLa 
cells and when co-expressed in Sf9 insect cells (Chowdhury, Liu et al. 2010). Interestingly, a 
strong interaction among these three proteins was not detected in G1 phase Xenopus egg extract 
(Figure 5A), which suggests that the interaction among DUE-B, Cdc45 and TopBP1 is tightly 
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regulated. Unlike the asynchronous HeLa cells, the G1 phase Xenopus egg extract is highly 
synchronized at the beginning of G1 phase and it enters S phase only when DNA template was 
added. As a result, it is not likely to capture the interaction among DUE-B, Cdc45 and TopBP1 if 
the interaction happens during the G1-S phase transition. It is equally possible that the 
interactions among these three proteins are weak in G1 phase of the cell cycle when the CDK and 
DDK kinase activity is low. In agreement with this idea, depletion of DUE-B, Cdc45 or TopBP1 
from G1 phase egg extract did not result in significant co-depletion of the other proteins (Figure 
5B).  
Summary  
Data presented in this section expanded the knowledge of how DUE-B participates in the 
DNA replication initiation process. Previously, we showed siRNA knockdown DUE-B in HeLa 
cells decreased chromatin bound Cdc45 and RPA suggesting DUE-B is important for Cdc45 
chromatin loading. Using Xenopus egg extract system, I was able to verify that DUE-B is 
necessary for Cdc45 binding to chromatin. Additionally, I showed that DUE-B chromatin binding 
requires MCM2-7 complex loading and CDK activation. At the same time, other lab members 
found DUE-B interacts with Cdc45 and TopBP1, suggesting that these three proteins might get 
loaded onto the chromatin at the same time in an interdependent manner. However, this 
interaction is strictly regulated and possibly transient during G1-S phase transition. Further work 
is needed to study the exact time point when DUE-B binds to Cdc45 and TopBP1 and how these 
interactions are regulated. 
	    
35	  
Figure 5. DUE-B does not interact with Cdc45 or TopBP1 in G1 phase Xenopus egg extract. 
 (A) Protein G beads were coupled with specific antibody against either DUE-B, Cdc45 or 
TopBP1 individually. Antibody conjugated beads were incubated with G1 phase egg extract in 4 
°C for 2 hours with continuous rotation. After incubation, the beads were spun down at 2,000x g 
for 2 minutes at 4 °C in a swinging bucket centrifuge. Supernatant was removed and the beads 
were washed with egg extraction (EB) buffer for 5 times. Bead bound proteins were analyzed 
using Western blot. (B) The egg extract incubated with antibody-conjugated beads as stated in 








II. Replication checkpoint negatively regulates DUE-B binding onto chromatin 
DNA replication checkpoint acts as a safeguard when DNA replication is challenged. The 
checkpoint stalls cell cycle, pauses DNA replication and inhibits late origin firing. Inhibition of 
DNA replication by checkpoint can act through pathways that suppress the kinase activity of S-
phase CDK (Falck, Mailand et al. 2001) and DDK (Costanzo, Shechter et al. 2003) as well as  
through pathways independent of CDK and DDK (Liu, Barkley et al. 2006; Lopez-Mosqueda, 
Maas et al. 2010; Zegerman and Diffley 2010). Importantly, most of these pathways converge 
onto suppressing Cdc45 chromatin loading and MCM activation. We have shown that DUE-B is 
a regulator of Cdc45 chromatin binding in higher organisms. It is interesting to know how does 
DUE-B chromatin binding pattern change in the presence of replication challenge. In order to 
answer this question, different agents that introduce different replication challenges were 
supplemented into Xenopus egg extract and both Cdc45 and DUE-B chromatin binding were 
examined. 
The checkpoint activated by aphidicolin inhibits both Cdc45 and DUE-B chromatin binding 
Aphidicolin inhibits the DNA polymerase α, δ and ε activity results in uncoupling the 
polymerases and the DNA unwinding helicase MCM. Under the treatment of aphidicolin, the 
processing speed of DNA polymerase was greatly decreased, single stranded DNA accumulates 
behind the unaffected helicase and serves as a platform for RPA binding, which in turn activates 
replication checkpoint response (Guo, Kumagai et al. 2000; Byun, Pacek et al. 2005). As 
expected, supplementing low concentration aphidicolin into egg extract led to increasing Chk1 
Ser344 phosphorylation while adding the checkpoint kinase inhibitor caffeine into egg extract 
completely abolished this phosphorylation (Figure 6B). Interestingly, we also observed high 
concentration aphidicolin inhibits checkpoint activation (Figure 6A and 6B). This phenomenon 
was reported before by Byun et al. 2005 and was reasoned as high concentration of aphidicolin 
inhibits polymerase α DNA primer synthesis that is necessary for checkpoint activation.  
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Figure 6. Low level of aphidicolin induces an ATR/Chk1 checkpoint while high 
concentration of aphidicolin inhibits Chk1 phosphorylation.   
(A) Xenopus egg extract with sperm chromatin was supplemented with 15 µM or 1 mM 
aphidicolin (APH) and incubated at room temperature. 5 µL total protein was collected at the 
indicated time points then analyzed by Western blot. (B) More aphidicolin concentrations were 










This hypothesis was proven to be true later that polymerase α is essential for recruiting 9-1-1 
complex onto stalled replication fork (Yan and Michael 2009). The results suggested that our 
Xenopus egg extract system was able to faithfully represent the checkpoint activation process. 
We then used this system to examine chromatin loading of Cdc45 and DUE-B under 
aphidicolin treatment. 150 µM aphidicolin dissolved in DMSO or equal volume of DMSO was 
added into egg extract at the same time as sperm chromatin. In the aphidicolin treated samples, 
Cdc45 chromatin binding was greatly inhibited as expected. Importantly, DUE-B chromatin 
binding was not detected in the aphidicolin treated samples (Figure 7A). In order to confirm that 
this inhibition of DUE-B loading was truly a result of checkpoint activation, 5 mM caffeine was 
introduced into some of the samples to inhibit the ATM/ATR kinase activity (Costanzo, Shechter 
et al. 2003). As shown in Figure 7B, caffeine is capable of partially reversing the inhibition of 
Cdc45 and DUE-B chromatin binding induced by aphidicolin. This result suggests that the 
deficiency of Cdc45 and DUE-B chromatin loading in the presence of aphidicolin was a result of 
ATM/ATR kinase activity. The detailed mechanism of how ATM/ATR inhibits Cdc45 is still not 
clear. But many models suggested that the CDK and DDK might be the target of checkpoint 
response (Heffernan, Simpson et al. 2002; Sancar, Lindsey-Boltz et al. 2004). It is possible that 
the deficiency of DUE-B loading onto chromatin was a result of Cdc2/Cyclin B inactivation but 
we were not able to rule out the possibility that the activity of DUE-B was directly inhibited 
through direct phosphorylation by checkpoint kinases at this point. 
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Figure 7. Checkpoint response activated by aphidicolin inhibits DUE-B and Cdc45 binding 
to chromatin. 
(A) 150 µM aphidicolin (APH) was added into Xenopus egg extract at the same time as the sperm 
chromatin. Sperm chromatin was isolated at indicated time points and the chromatin bound 
proteins were analyzed by Western blot. (B) 5 mM caffeine was added into egg extract then 
incubated at room temperature for 10 minutes. Then 150 µM aphidicolin and sperm chromatin 
was added into the extract at the same time. Sperm chromatin was isolated at 60 minutes after 






Checkpoint induced by etoposide inhibits DUE-B chromatin loading  
DNA damage induced by etoposide inhibits Cdc45 chromatin loading (Costanzo, Shechter et 
al. 2003). Different from aphidicolin, etoposide treatment generates breaks in DNA by inhibiting 
the topoisomerase II activity. Topoisomerase is a category of essential enzymes that are required 
for releasing the topological tension on DNA generated in many cellular events such as DNA 
replication, RNA transcription and chromatin remodeling. There are two classes of topoisomerase 
that differ in the mechanism of cutting the double helix. Type I topoisomerase nicks one of the 
two DNA strands while type II enzymes generate transient double stranded breaks (Champoux 
2001). Etoposide specifically blocks the religation step of the type II topoisomerase after double 
strand break (DSB) has been generated (Bromberg, Burgin et al. 2003). In the presence of 
etoposide, topoisomerase II is locked in a state where active site tyrosyl residues are covalently 
linked to the 5’ end of the DSB. The 3’ ends of the broken strands can be resected and activate 
checkpoint that preferentially inhibits the Cdc7/Dbf4 kinase activity (Costanzo, Shechter et al. 
2003). Because Cdc7/Dbf4 is another essential kinase that controls G1-S phase transition, it is 
interesting to know if DUE-B chromatin loading is affected by etoposide treatment. 
Thirty micro molar etoposide was added into G1 phase egg extract at the same time or after 
adding sperm chromatin and incubated for certain time. Surprisingly, when etoposide was added 
at the same time as the sperm chromatin, there was no significant checkpoint activation (Figure 
8B lanes 4-6) or inhibition of Cdc45 and DUE-B chromatin binding (Figure 8A lanes 2-7). The 
discrepancy may result from the nature of Xenopus egg extract system. There is no protein from 
egg extract in the sperm head DNA, thus every protein that binds to sperm DNA later has to 
originate from the egg extract. When egg extract was supplemented with etoposide, 
topoisomerase II binds to etoposide and inhibits the formation of the topoisomerase-DNA 
complex that triggers replication checkpoint (Burden, Kingma et al. 1996). DNA replication can 
still happen because topoisomerase I takes over part of the function of topoisomerase II with 
limited efficiency (DiNardo, Voelkel et al. 1984; Takasuga, Andoh et al. 1995). 
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Figure 8. Etoposide inhibits DUE-B and Cdc45 loading onto chromatin. The inhibition 
cannot be reversed by caffeine.   
(A) Thirty micro molar etoposide was added into egg extract with or without 5 mM caffeine. 
(left) Etoposide was added at the same time with sperm chromatin. Samples were incubated at 
room temperature for indicated time then chromatin bond proteins were isolated and analyzed by 
Western blot. (right) Etoposide was added at indicated time points after sperm chromatin was 
incubated with egg extract. All the samples were collected at 60 minutes after adding sperm 
chromatin. 
(B) 5 ul of total protein from (A) was also analyzed by Western blot for phospho-chk1 signal. 
Compared with the no etoposide control, additional ATR-Chk1 checkpoint signal, other than the 
basal level from normal DNA replication, can be triggered only when etoposide was added after 
DNA replication has initiated. 








 As shown in Figure 8A (left), Cdc45 and DUE-B chromatin loading peaks at 60 minutes in 
etoposide treated samples while the untreated egg extract peaks at 45 minutes. This result 
suggests potential delay of replication initiation without topoisomerase II activity. In agreement 
with this hypothesis, the S-phase checkpoint was not activated (Figure 8B lanes 4-6), adding 
caffeine abolished the basal level of phosphor-Chk1 signal but no change of the protein chromatin 
loading pattern was observed (Figure 8A lanes 8-10 and Figure 8B lanes 7-9).  
To understand better how etoposide regulates DUE-B and Cdc45 chromatin loading, the 
drug was added after sperm chromatin was incubated with egg extract, which allows the egg 
extract topoisomerase to engage sperm chromatin in advance. At the time of etoposide addition, it 
captures the intermediate state of the enzyme activity with the double stranded break and triggers 
checkpoint response. As expected, if etoposide was added 10 minutes after sperm chromatin was 
incubated with egg extract, both Cdc45 and DUE-B chromatin loading is greatly inhibited (Figure 
8A lane 12) accompanied with a slight increase of phosphorylated Chk1 signal (Figure 8B lane 
10). Interestingly, adding caffeine into etoposide treated sample could only slightly reverse the 
inhibitory effect of this checkpoint although the phospho-Chk1 signal is greatly diminished 
(Figure 8A lane 14 and Figure 8B lane 12). This finding agrees with the findings by Costanzo, 
Shechter et al. 2003 and suggests that the DNA-etoposide-topoisomerase II structure is able to 
trigger a checkpoint response to inhibit DNA replication initiation by blocking Cdc45 and DUE-
B chromatin binding. This inhibition could be a result of Cdc7 inactivation but only partially 
through the ATM/ATR signal pathway.  
When etoposide was added 40 minutes after sperm chromatin, a significant amount of 
Cdc45 was observed on the chromatin (Figure 8A lane 13) in spite of elevated level of 
phosphorylated Chk1 (Figure 8B lane 12). On the contrary, DUE-B chromatin binding was 
greatly inhibited comparing to the untreated samples. Adding caffeine into etoposide treated 
sample resulted in slightly higher amount of chromatin bound Cdc45 and DUE-B while 
completely inhibiting Chk1 phosphorylation (Figure 8A lane 15 and Figure 8B lane 13). This 
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result revealed the possibility that Cdc45 and DUE-B can be regulated differently under certain 
conditions.  
When sperm chromatin was incubated 10 minutes with the egg extract, only a small amount 
of chromatin bound Cdc45 and DUE-B were detected (Figure 8A lane 2). The etoposide induced 
DNA damage checkpoint under this condition would inhibit additional Cdc45 and DUE-B 
binding onto replication origin. After incubating sperm chromatin with egg extract for 40 minutes, 
many replication forks had been established as indicated by a significant amount of chromatin 
bound Cdc45 and DUE-B (Figure 8A lane 3). If etoposide was introduced into egg extract at this 
point, further recruitment of Cdc45 to late replication origins will be inhibited as a result of 
checkpoint activation. Meanwhile, topoisomerase II was covalently linked to DNA in the 
presence of etoposide, which act as a roadblock to prevent chromatin bound Cdc45 releasing 
from established replication fork. Unlike Cdc45, DUE-B is release from chromatin under this 
circumstance. This agrees with the fact that DUE-B does not move with replication fork and is 
released from chromatin during replication initiation. The significant inhibition of chromatin 
bound DUE-B could result from both inhibition of DUE-B binding to late origins and the release 
of DUE-B from early origins. Caffeine rescued part of the chromatin bound DUE-B suggesting 
that more DUE-B could bind to late origins when ATM/ATR kinase activity were suppressed. 
However, the effect of caffeine was very limited, which argues for other mechanisms that are 
independent of ATR/ATM activity that might be responsible for Cdc45 and DUE-B inhibition 






DUE-B chromatin loading is moderately sensitive to DNA double strand break 
Annealed poly(dA)70 nucleotides oligo with poly(dT)70 nucleotides oligo (dAdT) has been 
proven to be an effective template to mimic the structure of DNA double strand breaks in the 
Xenopus egg extract system (Kumagai and Dunphy 2000). This synthetic DNA template 
preferentially triggers Chk2 phosphorylation when incubated in Xenopus egg extract in the 
absence of any PP2A inhibitor (Guo, Kumagai et al. 2000). Double strand breaks inhibit Cdc45 
chromatin loading and DNA replication in Xenopus egg extract (Costanzo, Robertson et al. 2000; 
Petersen, Chou et al. 2006). We want to know if DUE-B is regulated in a similar pattern as Cdc45. 
Sperm chromatin was incubated in egg extract supplemented with dAdT and chromatin 
bound proteins were examined as described before. p27 was included in one sample as negative 
control. As expected, p27 inhibited the chromatin binding of every protein factor that requires 
CDK activity. On the other hand, dAdT treated sample presented small but reproducible 
inhibition on Cdc45, DUE-B and RPA32 chromatin binding but did not affect Orc2 loading 
(Figure 9). This finding agrees with previous discovery that the checkpoint activated by double 
strand break does not affect pre-RC formation while replication factors binding after MCM are 
inhibited. Although it is still under debate if CDK/DDK kinase activity is affected after double 
strand break (Costanzo, Robertson et al. 2000; Costanzo, Shechter et al. 2003; Petersen, Chou et 
al. 2006), it is clear that both Cdc45 and DUE-B are regulated in a similar manner under this 
condition.  
Protein phosphatase 2A is required for DUE-B chromatin binding 
Removal of protein phosphatase 2A (PP2A) from egg extracts prevents the initiation of 
DNA replication, but not elongation at existing replication forks (Lin, Walter et al. 1998). PP2A 
depletion inhibited Cdc45 loading but did not affect MCM or ORC binding to chromatin (Chou, 
Petersen et al. 2002). It was proposed that PP2A stimulates Cdc45 loading by dephosphorylating 
a protein that is essential for Cdc45 chromatin binding (Petersen, Chou et al. 2006). Since DUE-B 
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Figure 9. poly(dA)70-poly(dT)70 inhibits DUE-B loading onto chromatin.  
(A) Two hundred ug/ml poly(dA)70-poly(dT)70  (dAdT) was incubated with egg extract 10 
minutes before adding sperm chromatin. All samples were taken 60 minutes after adding sperm 
chromatin. 1 ul egg extract was used as positive control in lane 1. (B) Quantitation of Western 
blot signal intensity. Signals from each lane were normalized to the Mcm7 signal that would not 
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Figure 10. Okadaic acid inhibits DUE-B loading onto chromatin.   
Fifteen µM okadaic acid was incubated with egg extract for 10 minutes before adding sperm 
chromatin. Chromatin bond proteins were isolated then analyzed by Western blot 60 minutes after 
adding sperm chromatin.  
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is required for Cdc45 chromatin binding, we wanted to understand if PP2A is able to regulate 
DUE-B chromatin loading. 
Fifty micro molar okadaic acid was incubated with egg extract for 10 minutes before adding 
sperm chromatin to inhibit PP2A phosphatase activity as reported previously. Sperm chromatin 
was isolated from egg extract after incubating in egg extract with or without okadaic acid, and 
chromatin bound proteins were analyzed by Western blot. Both Cdc45 and DUE-B loading were 
modestly inhibited by okadaic acid indicating the chromatin loading of both replication factors 
were regulated through the same pathway or depend on each other. Consistent with Cdc45, RPA 
and PCNA chromatin loading is modestly decreased, as a result of inhibition of DNA unwinding 
activity (Figure 10).  
Under phosphorylated DUE-B is regulated differently from endogenous Xenopus DUE-B 
Our lab previously reported that DUE-B purified from insect cells (DUE-BSf9) dominantly 
inhibits double strand DNA replication in egg extract, while DUE-B purified from HeLa cells 
could complement replication in DUE-B depleted egg extract (Casper, Kemp et al. 2005). It was 
reasoned that this discrepancy might result from altered phosphorylation patterns on the protein 
when purified from different sources because DUE-BSf9 is unphosphorylated at the C-terminus 
tail compared to DUE-BHeLa synthesized in HeLa cells (Kemp, Bae et al. 2007). Given the distinct 
nature of DUE-BSf9 it is important to know if DUE-BSf9 can be regulated in the same way as the 
Xenopus DUE-B.  
Wild type human DUE-B (WT) or C-terminus deleted (missing amino acids 151-209) 
human DUE-B (ΔCT) expressed in Sf9 insect cells were added into G1 phase Xenopus egg 
extract separately in the presence of geminin, p27 or aphidicolin (Figure 11). Exogenous DUE-B 
was added to only 10 percent of the amount of endogenous DUE-B (Figure 11 lane 1 and 2). 
Strikingly, more than 10 fold exogenous DUE-B was observed on the chromatin compared to the 
endogenous protein after 60 minutes incubation with chromatin  (lane 3 and 8). This suggests that 
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DUE-B purified from insect cells has a higher affinity to chromatin than the endogenous DUE-B 
possibly due to its lower level of phosphorylation. Consistent with previous findings, endogenous 
DUE-B chromatin loading was inhibited by geminin, p27 and aphidicolin in the presence of 
exogenous DUE-B. During replication initiation, WT DUE-BSf9 gradually bound to the chromatin 
in the same way as endogenous DUE-B. WT DUE-BSf9 was also sensitive to geminin and p27 
treatment (Lane 5 and 6) implying WT DUE-BSf9 chromatin binding also requires pre-RC 
formation and CDK kinase activity. Interestingly, aphidicolin did not significantly block WT 
DUE-BSf9 chromatin loading (lane 7). If aphidicolin blocks DUE-B chromatin loading by 
inhibiting CDK kinase activity, aphidicolin should inhibit exogenous WT-DUE-BSf9 chromatin 
binding regardless of the difference between DUE-BSf9 and endogenous DUE-B, as does p27. The 
inability of aphidicolin to inhibit DUE-BSf9 chromatin loading suggests that the checkpoint 
activated by aphidicolin does not regulate DUE-BSf9 chromatin binding by inhibiting CDK kinase 
activity. The fact WT DUE-BSf9 was not sensitive to aphidicolin also indicates the 
posttranslational modification on DUE-B is important for regulating its function. 
On the contrary, ΔCT DUE-BSf9 robustly bound to chromatin soon after sperm DNA was 
added into the egg extract (lane 9, untreated sample). Most surprisingly, ΔCT DUE-BSf9 was not 
responding to any of these treatments although endogenous DUE-B chromatin binding was still 
inhibited by geminin, p27 and aphidicolin. Importantly, this result reveals that the C-terminus tail 
is essential for regulating DUE-B binding onto replication origins. Truncation of the DUE-B C-
terminus could result in uncontrolled chromatin binding of DUE-B that is independent of pre-RC 
and CDK activity.  
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Figure 11. DUE-BSf9 hyper loads onto chromatin and is regulated differently from the 
endogenous DUE-B.  
Geminin (Gem), p27 or aphidicolin (Aph) was incubated with Xenopus egg extract supplemented 
with either WT DUE-BSf9 or ΔCT DUE-BSf9 for 10 minutes before adding sperm chromatin. 
Chromatin bond proteins were isolated at indicated time points and analyzed by Western blot. 




DUE-B or Orc2 is not necessary for checkpoint activation 
Many DNA replication proteins serve in replication checkpoint activation. For example, 
TopBP1 directly interacts with ATR and activates its kinase activity when replication is 
challenged (Kumagai, Lee et al. 2006). Both TopBP1 and DNA polymerase alpha are required to 
recruit the 9-1-1 complex onto stalled replication forks (Yan and Michael 2009). RPA 
accumulating on single stranded DNA acts as a stimulus for checkpoint activation (Zou and 
Elledge 2003). In the previous protein immunodepletion experiments, inhibition of basal level 
Chk1 phosphorylation during DNA replication was repeatedly observed in Orc2, TopBP1 and 
DUE-B depleted samples (Figure 12A). The suppression of phospho-Chk1 signal in replication 
factor depleted samples could be because Orc2 and DUE-B are involved in checkpoint activation 
similar to the situation of TopBP1. It is also possible that depletion of any of these proteins 
abolishes DNA replication that is required for basal level of Chk1 activation (Lupardus, Byun et 
al. 2002).  
In order to test both hypotheses, dAdT was added into G1 phase Xenopus egg extract at the 
same time as okadaic acid.  Under this condition, dAdT can trigger a massive checkpoint 
activation, resulting in high level of Chk1 phosphorylation without DNA replication (Kumagai 
and Dunphy 2000). This phospho-Chk1 signal was completely inhibited in the absence of 
TopBP1 consistent with the role of TopBP1 in checkpoint activation. However, depletion of 
either Orc2 or DUE-B did not affect the accumulation of phosphorylated Chk1 in the presence of 
dAdT. This result validated that both DUE-B and Orc2 are essential for DNA replication 
initiation but are not necessary for checkpoint activation in the presence of dAdT. 
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Figure 12. DUE-B is not involved in checkpoint activation.  
(A) Depletion of Orc2, TopBP1 and DUE-B inhibits basal level Chk1 phosphorylating induced 
by DNA replication. (B) Depletion of TopBP1 diminished Chk1 phosphorylation induced by 
dAdT while depletion of DUE-B or Orc2 did not affect checkpoint activation. The asterisk 
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Summary  
The S-phase checkpoint inhibits late replication origin firing by blocking pre-IC formation 
through multiple mechanisms. Cdc45 has been shown to be an important factor that is sensitive to 
many forms of DNA damage. In this study, we found endogenous wild type DUE-B chromatin 
binding is inhibited in all the conditions tested that have been shown to inhibit Cdc45 chromatin 
loading. This result suggests that the mechanisms regulating both DUE-B and Cdc45 may be 
similar or dependent on each other. Interestingly, two groups independently reported that budding 
yeast Sld3 activity was negatively regulated by Chk1 phosphorylation during DNA damage 
response (Lopez-Mosqueda, Maas et al. 2010; Zegerman and Diffley 2010). Their results shed 
light on the possibility that inhibition of Cdc45 chromatin loading might be a result of direct 
inhibition on the higher organism Sld3 ortholog. The result presented in Figure 11 suggested that 
aphidicolin inhibits DUE-B chromatin loading independent of Cdk2 kinase activity. It is possible 
that DUE-B is a direct target of some checkpoint response that inhibits Cdc45 loading. Further 
studies are needed to provide direct evidence if any of the checkpoint kinases could direct 
regulate DUE-B activity in Cdc45 chromatin loading. Additionally, results presented here show 
that the C-terminus of DUE-B is essential for control of DUE-B loading possibly through the 
effects of phosphorylation.  
III. DUE-B can be phosphorylated during replication initiation 
Fluctuation of kinase activity is the primary driving force for the control of the cell cycle 
progression. Although studies in yeast showed that Cdk1 is only essential kinase in controlling 
the cell cycle, there are different kinases in each phase of the cell cycle that assist the Cdk1 to 
ensure the accuracy and efficiency of cell cycle progression (Coudreuse and Nurse 2010). In S-
phase of the cell cycle, the most important players are DDK and S-phase CDK. Both kinases 
activate during the G1 to S phase transition and convert pre-RC to pre-IC. DDK primarily 
phosphorylates MCM complexes while CDK targets Sld3 and Sld2 in yeast. Both events are 
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necessary for Cdc45 chromatin binding and MCM activation. We have shown that both DUE-B 
and Cdc45 require Cdk2 kinase activity to bind chromatin. Underphosphorylated DUE-BSf9 
inhibits DNA replication when added into Xenopus egg extract. Phosphorylating DUE-B with 
casein kinase II weakens the interaction between DUE-B and Cdc45. It is possible that DUE-B 
phosphorylation during replication initiation might play an important role in regulating its activity 
like many other replication factors. In this chapter, phosphorylation of DUE-B is examined in 
vivo and in vitro. 
Endogenous DUE-B is phosphorylated during replication initiation 
In order to assay DUE-B phosphorylation during replication initiation, G1 phase Xenopus 
egg extract was supplemented with ϒ -[32P]-ATP before sperm chromatin was added. DUE-B 
from the egg extract was purified using specific antibody after DNA replication initiation. ϒ -32P 
incorporation was detected by X-ray film. Using this experiment, phosphorylation on DUE-B was 
detected in DUE-B antibody pull-down samples (Figure 13). This result showed direct evidence 
that DUE-B can be phosphorylated during replication initiation. However, the level of ϒ-32P 
incorporation on DUE-B is quite low and takes long time to detect when exposed to X-ray film. It 
suggests that only a small fraction of total DUE-B keeps the ϒ-32P labeling during the DNA 
replication initiation process. This phenomenon could be because DUE-B is phosphorylated 
during replication initiation but is dephosphorylated immediately after carrying out its function. 
This is consistent with the protein chromatin binding results that only a small fraction of DUE-B 
is transiently loaded onto the chromatin (Figure 1). Both data suggests DUE-B may act 
enzymatically in facilitating DNA replication initiation. 
To test whether DUE-B phosphorylation is conserved through out evolution. HeLa cells 
were synchronized in M phase using 50 nM nocodazole for 24 hours. Synchronized cells were 
released into fresh medium and samples were collected after indicated time. DUE-B was 
immunoprecipitated from cell extract and analyzed for total phosphorylated serine and threonine 
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using phosphospecific antibody. DUE-B phosphorylation increased over 2 fold just 1 hour after 
release from M phase block. The level of phosphorylation kept increasing as cells progressed into 
G1and S phase (Figure 14A). This increasing phosphorylation on DUE-B correlated well with the 
cell cycle progression detected by flow cytometer as many cells move out of M phase after 2 
hours release and migrated into S phase 6 hours after release (Figure 14B). This result agrees with 
the finding in Xenopus egg extract that DUE-B gets phosphorylated when cells enter S-phase. 
Additionally, it provides evidence that DUE-B also gets phosphorylated during M to G1 phase 
transition. Both phosphorylations could potentially regulate the activity of DUE-B in supporting 
DNA replication.  
My data confirmed the previous results using cell cycle inhibitors that DUE-B harbors the 
lowest phosphorylation level in M phase of the cell cycle and highest phosphorylation during the 
S phase (Casper, Kemp et al. 2005). In the previous research, many agents were used to 
synchronize cells at different phases of the cell cycle. However, many chemicals are now known 
to introduce a DNA damage checkpoint, which could possibly inhibit DUE-B phosphorylation or 
lead to phosphorylation of DUE-B. My experiments did not include any chemical that would 
introduce a DNA damage checkpoint and thus ruled out the interference of checkpoint kinase on 
DUE-B phosphorylation. Together, phosphorylation of DUE-B when cell migrates into S phase 
positively correlates with cell cycle progression and DNA replication. 
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Figure 13. Endogenous Xenopus DUE-B can be phosphorylated during replication 
initiation.  
Xenopus egg extract was supplemented with 0.22 uCi/ul ϒ-32P-ATP. Sperm chromatin was 
incubated with egg extract at room temperature. Reaction was stopped by adding IP buffer in the 
presence of protease inhibitor and phosphatase inhibitor cocktail. The stopped reaction was 
sonicated and then centrifuged at maximum speed in a micro centrifuge at 4 °C. 10 ul protein G 
beads conjugated with either normal rabbit IgG or DUE-B antibody were incubated with cleared 
extract supernatant overnight. Beads were washed 5 times with IP buffer then the bead bound 







	    
57	  
Figure 14. DUE-B phosphorylation level increases in S-phase human cells.  
(A) HeLa cells were blocked with 50 nM nocodazole for 24 hours, and then cells were released 
into fresh complete medium. Cells were collected at indicated time points. Total protein was 
extracted using M-per buffer (Thermo Scientific) supplemented with phosphatase inhibitor and 
protease inhibitor cocktail. Cells were sonicated and centrifuged to get clear lysate. DUE-B was 
immunoprecipitated from cell extracts and probed for phosphorylated Ser/Thr using specific 
phosphospecific antibody. (B) Cells collected from A were stained with propidium iodide after 
RNase digestion and checked for DNA content using flow cytometer.  
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DUE-B can be phosphorylated at threonine 187 by Cdk2 in vitro 
CDK is the major kinase to drive the cell cycle forward. In an extreme case, yeast containing 
a single cyclin-Cdk1 protein is able to complete the whole cell cycle (Coudreuse and Nurse 
2010). Cdk2 is the major kinase controlling DNA replication initiation in higher organisms. In 
order to test if Cdk2 directly phosphorylates DUE-B, I performed in vitro kinase assay using 
commercially purified cyclin-Cdk2 and recombinant human DUE-B purified from different 
sources in the presence of ϒ-[32P]-ATP. Recombinant human histone H1 was included as a 
positive control for Cdk2 kinase activity in all the kinase assays.  
We first tested if DUE-B purified from human cells and insect cells can be phosphorylated 
differently by Cdk2 in vitro. Equal amounts of DUE-BHeLa and DUE-BSf9 and histone H1 were 
incubated with Cdk2 at room temperature. Both histone H1 and DUE-BSf9 showed strong 32P 
incorporation indicating they are all Cdk2 substrates in vitro (Figure 15). Interestingly, DUE-
BHeLa incubated with Cdk2 showed significantly less radioactive signal than the DUE-BSf9, 
suggesting DUE-BHeLa may have some residues already phosphorylated and cannot be modified 
by Cdk2 in the kinase assay. This is consistent with previous finding that DUE-B purified from 
HeLa cells has more phosphorylated residues than that purified from insect cells (Kemp 2006).  
Knowing that DUE-BSf9 can be phosphorylated by Cdk2 in vitro, we decided to find out 
what residues were responsible for this phosphorylation. Cdk2 phosphorylates the first serine or 
threonine in the conserved S/TP domain. There are two such domains in the DUE-B C-terminus, 
S(147)P and T(187)P. We first constructed and purified the C-terminus truncated DUE-B in 
E.coli and found that the ΔCT DUE-B could no longer incorporate radioactive signal (Figure 16). 
As expected, the histone H1 was heavily phosphorylated while the BSA did not have any non-
specific 32P incorporation. This result suggested that the Cdk2 phosphorylation on DUE-B is 
depended on the C-terminus. Then, specific site mutations were made changing the S147, T187 
or both S147/T187 to alanine. Same amount of DUE-B mutations were used in the Cdk2 kinase 
assay. As shown in Figure 17A, T187 to alanine mutant greatly diminished DUE-B 
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phosphorylation while no detectable change was observed in the S147A or S147A/T187A double 
mutant. In more exposed films, a weak band representing phosphorylation in the S147A mutant 
was detected while the double mutant did not have any detectable phosphorylation suggesting 
that S147 may not be a favorite site for Cdk2 in vitro (Figure 16B). Additionally, we tested if p27 
can inhibit Cdk2 kinase activity towards DUE-B. As shown is Figure 18, p27 strongly inhibited 
Cdk2 kinase activity to all samples analyzed in our kinase assay. 
Together, the kinase assays presented above using different DUE-B mutants as substrates 
identified DUE-B as a target for Cdk2 in vitro. Cdk2 phosphorylation is dependent on T187 
suggesting that T187 is a major phosphorylation site in DUE-B. On the other hand, some 
phosphorylation on S147 is also detected. A small mobility shift was observed when DUE-B is 
phosphorylated (Figure 17A). Interestingly, when comparing the position of WT-DUE-B in the 
presence and absence of Cdk2 inhibitor (using the unphosphorylatable S147A/T187A double 
mutant as reference), phosphorylated DUE-B migrates slightly faster than unphosphorylated 
protein on SDS-PAGE.  
Summary  
Data presented in this chapter showed that DUE-B is phosphorylated during the M to S 
phase of the cell cycle. Increasing DUE-B phosphorylation correlates well with DNA replication 
initiation. Cdk2 could account for the phosphorylation during G1 to S phase transition in HeLa 
cells but the kinase that phosphorylates DUE-B in M to G1 phase transition is still unknown. 
DUE-BHeLa and DUE-BSf9 have different sensitivity to Cdk2 kinase suggesting that they might 
carry different level of phosphorylated residues when produced in the host cell, as reported 
previously. Different phosphorylation level in DUE-B purified from different source could give 
them distinct properties in supporting DNA replication. This possibility is investigated further 
below. 
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Figure 15. Cdk2 can phosphorylate DUE-B purified from different sources at different 
levels.  
The same amount of histone H1, DUE-B purified from HeLa or Sf9 cells were incubated with 
100 units of Cdk2-cyclin A in the presence of 0.1 uCi/ul ϒ-[32P]-ATP for 30 minutes. Proteins 
were separated by SDS-PAGE. Gel was dried and exposed to X-ray film at -80 °C overnight. 2 
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Figure 16. Cdk2 can phosphorylate WT DUE-B but not C-terminus truncated DUE-B.  
The same amount of Histone H1, BSA, WT DUE-B and ΔCT DUE-B were incubated with 100 
units of Cdk2-cyclin A in the presence of 0.1 uCi/ul ϒ-32P-ATP for 30 minutes. Proteins were 
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Figure 17. Cdk2-cyclinA phosphorylates DUE-B in vitro at T187. Phosphorylated DUE-B 
migrates faster on SDS-PAGE.  
The same amount of DUE-B mutants were incubated with 100 units of Cdk2-cyclin A in the 
presence of 0.1 uCi/ul ϒ-[32P]-ATP for 30 minutes. Proteins were separated by SDS-PAGE. Gel 









Figure 18. Cdk2 kinase activity can be specifically inhibited by p27.  
The same amount of DUE-B mutants were incubated with 100 units of Cdk2-cyclin A in the 
presence of 0.1 uCi/ul ϒ-[32P]-ATP for 30 minutes. Proteins were separated by SDS-PAGE. Gel 
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IV. DUE-B is part of high molecular weight complexes during certain phases of the cell 
cycle 
Previous research reported DUE-BSf9 was incorporated into high molecular weight 
complexes when incubated with G1 phase egg extract or HeLa nuclear extract while endogenous 
DUE-B was only detected as dimer (Casper, Kemp et al. 2005). Given the fact that endogenous 
and exogenous DUE-B have the same amino acid sequences, it was reasoned that different 
phosphorylation levels between endogenous and exogenous DUE-B affected their ability to 
interact with other proteins because DUE-BHeLa has more phosphorylated residues than DUE-BSf9.  
Endogenous DUE-B is incorporated into high molecular weight complexes during certain 
phases of the cell cycle 
We already showed that endogenous DUE-B has the lowest phosphorylation level during M 
phase of the cell cycle. It is interesting to know whether or not endogenous DUE-B can also form 
high molecular weight complexes in M phase cells. HeLa cells were synchronized with 50 nM 
nocodazole for 24 hours in M phase or released into fresh medium for 2 hours (Figure 19C). Cells 
were collected and lysed in EB buffer containing phosphatase inhibitor and protease inhibitor 
cocktail. Clear lysate was loaded onto a Sephacryl S-400 HR gel filtration column and eluted with 
EB buffer. Fractions were separated by SDS-PAGE and analyzed by Western blot using specific 
antibodies. As expected, a fraction of endogenous DUE-B was found in high molecular weight 
complexes in M phase cell lysate (Figure 19A). On the other hand, the majority of DUE-B in the 
high molecular weight complexes disappeared when cells were released from nocodazole block 
(Figure 19B). This result suggests that a subset of endogenous DUE-B in M phase cells can form 
high molecular weight complexes with other proteins, similar to the formation of a high 
molecular weight complex by DUE-BSf9 in previous research (Casper, Kemp et al. 2005).  
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Figure 19. A fraction of DUE-B was incorporated in a high molecular weight complex in M 
phase HeLa cells.  
(A) HeLa cells were synchronized in M phase with nocodazole for 24 hours. Proteins were 
extracted from cells by sonication and loaded onto Sephacryl S-400 HR gel filtration column. 
Fractions were then analyzed by Western blotting. (B) High molecular weight complex resolved 
shortly after releasing from M phase. Nocodazole synchronized HeLa cells were released into 
drug free medium for 2 hours. Proteins were extracted from cells by sonication and loaded onto 
gel filtration column. The proteins are separated by their molecular weight in the native form. 
Fractions were then analyzed by Western blotting. (C) Flow cytometer analysis of DNA content 








However, nocodazole blocks cell cycle progression by inhibiting microtubule assembly that 
would potentially disturb the organization of molecules in cell. To rule out the possibility that the 
high molecular weight complexes is a result of nocodazole treatment, the formation of high 
molecular weight complexes was examined using M phase Xenopus egg extract. Xenopus eggs 
are naturally synchronized in M phase of cell cycle before fertilizing (Lebofsky, Takahashi et al. 
2009), they do not contain any drugs that would potentially interfere with the result. M phase and 
G1 phase egg extract were prepared and fractionated using the same gel filtration column. 
Consistent with the finding in HeLa cells, Xenopus DUE-B was incorporated in a high molecular 
weight complexes during the M phase of the cell cycle (Figure 20A). Likewise, no high 
molecular weight complexes were detected in G1 phase egg extract (Figure 20B). Parallel results 
from both systems implied that a fraction of DUE-B is incorporated into high molecular weight 
complexes during M phase of the cell cycle and this phenomenon is conserved during evolution.  
We expanded our study in Xenopus egg extract to late S phase of the cell cycle by 
replicating sperm DNA in G1 phase egg extract. Xenopus egg extract is able to finish replicating 
the entire genome in 60 minutes (Dimitrova and Gilbert 1998; Ishikawa, Ohsumi et al. 2011). 80 
minutes after DNA replication initiation, proteins from egg extract were isolated and fractionated. 
Interestingly, only a very small amount of endogenous DUE-B was observed in the high 
molecular weight form. This result suggests that the DUE-B high molecular weight complexes 
dissociate during M to G1 phase of the cell cycle and DUE-B starts to get incorporated into high 
molecular weight complexes after DNA replication has finished.  
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Figure 20. A fraction of DUE-B is part of a high molecular weight complex in M phase 
Xenopus egg extract. DUE-B in high molecular weight complex shows a mobility shift.  
(A) M phase egg extract was loaded onto Sephacryl S-400 HR gel filtration column. The proteins 
were separated by their molecular weight in the native form. Fractions were then subjected to 
SDS PAGE and Western blotting. (B) DUE-B forms dimer in G1 phase Xenopus egg extract. G1 
phase egg extract was loaded onto gel filtration column. The proteins were separated by their 
molecular weight in the native form. Fractions were then subjected to SDS-PAGE and Western 
blotting. (C) Western blot signal intensity was measured and plotted along the X-axis according 
to the elute volume (Ve) from the column. Data from A and B were merged and presented 
together. DUE-B distribution overlapped well in the dimer region while significantly different in 
the high molecular weight region. (D) G1 phase egg extract was supplemented with sperm 
chromatin and then incubated at room temperature for 80 minutes. After incubation, the extract 
was supplemented with 0.1% SDS, sonicated and centrifuged at 16,000 g for 10 minutes. 
Supernatant was loaded onto gel filtration column. Fractions were then subjected to SDS-PAGE 
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DUE-B in homodimer is sensitive to phosphatase treatment 
Comparing the mobility of DUE-B in high molecular weight complexes to that in dimer 
form, a small but reproducible shift is evident in the M phase HeLa extract and Xenopus egg 
extract (Figure 19A and Figure 20A). Since I have shown that phosphorylated DUE-B migrates 
faster on SDS-PAGE (Figure 17A), it is possible that DUE-B in the high molecular weight 
complexes is de-phosphorylated while the homodimer only contains phosphorylated DUE-B. To 
test whether DUE-B in the dimer form was phosphorylated, we isolated DUE-B from the 
fractions that contain DUE-B dimer then treated it with lambda phosphatase. As shown in Figure 
21A, DUE-B in dimer form is sensitive to phosphatase treatment. Phosphatase treated DUE-B 
migrated slightly slower than untreated sample or sample incubated with both phosphatase and 
phosphatase inhibitor cocktail. Consistent with Figure 17, the slower migration band in 
phosphatase treated samples indicates less phosphorylation on DUE-B molecule. We also 
immunoprecipitated DUE-B from G1 phase egg extract and proved that all DUE-B in G1 phase 
egg extract was sensitive to phosphatase treatment (Figure 21B), which is consistent with all 
DUE-B in G1 phase egg extract forming phosphorylated dimers (Figure 20B). Samples from 
Figure 21B were loaded onto the gel repeatedly to show that the subtle mobility shift presented in 
panel A and B are not an artifact caused by accidental distortion in the gel (Figure 21C). 
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Figure 21. DUE-B that forms dimer is susceptible to phosphatase modification and showed 
slight mobility shift after phosphatase treatment.  
(A) DUE-B dimers from G1 phase extract were isolated by gel filtration. The DUE-B dimers 
were then treated with lambda phosphatase in the presence or absence of phosphatase inhibitor. 
(B) Majority of DUE-B in G1 phase egg extract are phosphorylated and phosphorylated DUE-B 
migrates faster on SDS-PAGE.  DUE-B was immunoprecipitated from the G1 phase egg extract 
with DUE-B antibody. Then the precipitate was treated with lambda phosphatase in the presence 
or absence of phosphatase inhibitor.  












By using gel filtration technique, we were able to show that endogenous DUE-B is 
incorporated into high molecular weight complexes during M phase but not in G1 phase of the 
cell cycle. The formation of high molecular weight complexes is inhibited after DNA replication 
initiation and re-occurred after replication has finished. This data suggests that the high molecular 
weight complexes formation is associated with cell cycle progression and potentially relates to 
DUE-B phosphorylation during the cell cycle. Interestingly, a small mobility shift was observed 
between DUE-B in high molecular weight complexes and in the dimer form. Also, DUE-B in the 
dimer form were susceptible to phosphatase treatment suggesting phosphorylation of DUE-B 
could be important for regulating high molecular weight complexes formation. More research is 
needed to study the role of DUE-B phosphorylation in controlling high molecular weight 
complexes formation. 
V. Incorporation of DUE-B into high molecular weight complexes is controlled by multiple 
kinases and phosphatase 
We reported that a fraction of DUE-B forms high molecular weight complexes during M 
phase of the cell cycle, when the DUE-B phosphorylation level is low. The DUE-B in the high 
molecular weight complexes migrates slower on SDS-PAGE similar to DUE-B treated with 
phosphatase. Previous research showed that DUE-BSf9 has lower phosphorylation level than the 
endogenous Xenopus DUE-B or HeLa DUE-B. Interestingly enough, DUE-BSf9 forms high 
molecular weight complexes when incubated with egg extract. It is possible that phosphorylated 
DUE-B forms dimers while the dephosphorylated DUE-B gets incorporated into the high 
molecular weight complexes. In this chapter, more direct evidence is provided to explain how 
phosphorylation controls the formation of DUE-B high molecular weight complexes.  
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DUE-BSf9 forms high molecular weight complexes in G1 phase egg extract 
In order to study the relationship between DUE-B phosphorylation and high molecular 
weight complexes formation, we utilized DUE-B purified from Sf9 insect cells which has been 
shown to form high molecular weight complexes when incubated in Xenopus egg extract (Casper, 
Kemp et al. 2005). In our previously published work, the high molecular weight complexes were 
analyzed using a Sephacryl S-200 HR column that has an effective separating range from 5-250 
kD for globular proteins. The high molecular weight complexes containing DUE-B were eluted in 
the first few fractions after the void volume and were predicted to have a molecular weight 
greater than 250 kD. To determine the molecular weight of the high molecular weight complexes, 
a Sephacryl S-400 HR column that is able to separate globular proteins ranging from 20 kD to 
8000 kD was introduced in this research. Protein standards were separated on this column, and 
standard curves were generated according to the elution volume of each protein (Figure 22A). 
The standard curves were highly reproducible between runs. As shown in Figure 22B purified 
DUE-BSf9 was eluted almost at the same time as BSA, which agrees with previous findings that 
DUE-BSf9 forms homodimers. However, after incubating with G1 phase egg extract in the 
absence of any DNA, a fraction of DUE-BSf9 eluted from gel filtration column as a high 
molecular weight complex with apparent molecular weight about 4000 kD (Figure 22A and 22C). 
In contrast, endogenous Xenopus DUE-B (DUE-Bxl) was eluted as dimer as it was in untreated 
egg extract. Formation of the high molecular weight complexes did not affect the distribution of 
endogenous DUE-B on the gel filtration column. This finding suggests that DUE-BSf9 and 
endogenous DUE-Bxl have distinct ability of binding other proteins, which could result from the 
unique phosphorylation state of DUE-BSf9 and Xenopus DUE-B in G1 phase egg extract as 
discussed above.  
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Figure 22. A fraction of DUE-BSf9 can be incorporated into a high molecular weight 
complex when incubated with G1 phase egg extract.  
(A) Protein standards were fractionated using the Sephacryl S-400 HR column. Standard curve 
were plotted according to the molecular weight and elution volume of the specific proteins. 
Protein standards used in the analysis were thyroglobulin (~670 kD), alcohol dehydrogenases 
(~150 kD), bovine serum albumin (~66 kD) and cytochrome C (~12.4 kD). (B) DUE-B purified 
from Sf9 insect cells was fractionated by gel filtration column and analyzed by Western blot. (C) 
DUE-BSf9 was incubated with G1 phase egg extract at room temperature for 30 minutes. Then the 
extract was loaded onto gel filtration column. Fractions were then subjected to SDS-PAGE and 








Phosphorylation regulates DUE-BSf9 incorporation into high molecular weight complexes 
Interestingly, only a fraction of DUE-BSf9 was incorporated into the high molecular weight 
complexes while significant amount of DUE-BSf9 moved in dimer form as the endogenous DUE-
Bxl did. There are several possible reasons for this phenomenon. Firstly, DUE-B forms 
homodimer in G1 phase egg extract and in crystal structure (Kemp, Bae et al. 2007). It is possible 
that part of DUE-BSf9 dimerized with DUE-Bxl during the incubation and the DUE-BSf9-DUE-Bxl 
heterodimer lost the activity of binding to other proteins due to phosphorylation on DUE-Bxl 
(Figure 23A). Secondly, it is possible that the amount of DUE-BSf9 added into Xenopus egg 
extract exhausted its binding partner thus a fraction of DUE-BSf9 was left as free dimer. Finally, it 
is possible that a kinase or multiple kinases phosphorylates DUE-BSf9 as soon as DUE-BSf9 was 
added into the egg extract.  
To test whether or not endogenous DUE-B interferes with DUE-BSf9 binding with other 
protein, DUE-Bxl was depleted from G1 phase egg extract before adding DUE-BSf9. After 30 
minutes of incubation, proteins were fractionated using gel filtration. Depletion of endogenous 
DUE-B by greater than 80% did not significantly change the distribution of DUE-BSf9 (Figure 
23B and Figure 23C) suggesting that endogenous DUE-Bxl is not able to affect DUE-BSf9 binding 
to other proteins. Next, we tested whether the DUE-BSf9 in the dimer form is a result of depletion 
of its binding partners. Different concentrations of DUE-BSf9 were incubated with G1 phase egg 
extract and fractionated using gel filtration. However, the ratio of DUE-BSf9 in high molecular 
weight complexes to that in dimer form stayed the same while the amount of total DUE-BSf9 
incubated with egg extract differed 10 times in two samples (Figure 24). This result implies that 
in the concentration range tested (4 µg/mL-40 µg/mL), DUE-BSf9 is not able to completely 
deplete the binding factor from the egg extract. Instead, high molecular weight complexes 
formation inhibited DNA replication efficiency in treated egg extracts by decreasing the 
concentration of one or more DUE-BSf9 binding partners. This is consistent with previous findings 
	    
77	  
Figure 23. Endogenous DUE-B does not regulate DUE-BSf9 distribution.  
(A) Left, DUE-BSf9 homodimer forms high molecular weight complexes without endogenous 
DUE-Bxl. Right, if DUE-BSf9 forms heterodimer with DUE-Bxl during incubation and the 
heterodimer cannot bind to other protein, then a fraction of DUE-BSf9 will migrate in the dimer 
fraction with DUE-Bxl. (B) DUE-BSf9 was incubated with G1 phase egg extract. (C) DUE-BSf9 
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Figure 24. The amount of DUE-B in high molecular weight complex is not related to the 
amount of exogenous DUE-B added into the reaction.   
Increasing amount of DUE-BSf9 was incubated with G1 phase egg extract. Then the extract was 
loaded onto gel filtration columns. Fractions were then subjected to SDS-PAGE and Western 
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that DUE-BSf9 dominantly inhibits DNA replication in a dose dependent manner (Casper, Kemp 
et al. 2005). These findings also favor the possibility that there might be kinase(s) and 
phosphatase(s) in G1 phase egg extract that maintain the equilibration of DUE-BSf9 
phosphorylation.  
A previous lab member has shown that casein kinase II (CKII) is able to phosphorylate 
DUE-BSf9 at the C-terminus tail in vitro. We also reported that there are conserved CKII 
phosphorylation sites located in a peptide fragment that was differentially phosphorylated 
between DUE-BSf9 and DUE-BHeLa  (Michael Kemp 2006). To test if phosphorylation on DUE-B 
would modulate its ability to bind other proteins, DUE-BSf9 was phosphorylated by purified CKII 
in vitro and then incubated with untreated G1 phase egg extract for 30 minutes. Proteins were 
fractionated by gel filtration column and then analyzed by Western blotting. In agreement with 
our hypothesis, phosphorylation by CKII dramatically decreased DUE-BSf9 incorporation into the 
high molecular weight complexes (Figure 25A and 25B). This result directly proved that DUE-B 
phosphorylation decreases its protein binding activity and promotes its disassociation from high 
molecular weight complexes. It also argues that CKII could be one of the enzymes that regulate 
DUE-B activity under physiological conditions. Consequently, if DUE-BSf9 was phosphorylated 
by CKII or an other kinase during the incubation with G1 phase egg extract, this phosphorylation 
could give rise to the DUE-BSf9 dimer peak that moves with endogenous DUE-B dimer on the gel 
filtration column. 
Although phosphorylation by CKII greatly moved DUE-BSf9 into dimer form when 
incubated in G1 phase egg extract, there is still over 15% of total DUE-BSf9 left in the high 
molecular weight complexes. The DUE-BSf9 left in high molecular weight complexes could be 
because CKII did not completely phosphorylate all the DUE-BSf9 before adding into the egg 
extract. But it is also possible that there might be a phosphatase which counteracts DUE-B 
phosphorylation in G1 phase egg extract. To test if there is active phosphatase activity towards 
DUE-BSf9 in egg extract, DUE-BSf9 was incubated with G1 phase egg extract in the presence of  
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Figure 25. Phosphorylation by Casein Kinase II moves DUE-B into dimmer form.  
(A) DUE-BSf9 was incubated with G1 phase egg extract. (B) DUE-BSf9 was pre-phosphorylated by 
casein kinase II before adding into G1 phase egg extract. Phosphorylated DUE-BSf9  was then 
incubated with egg extract for 30 minutes. (C) Schematic of phosphorylation releases DUE-B 












phosphatase inhibitor cocktail. Proteins were fractionated and analyzed as in Figure 25. In the 
presence of phosphatase inhibitors cocktail, decreased amount of DUE-BSf9 was detected in high 
molecular weight complexes (Figure 26A and 26B), which indicates that general inhibition of the 
phosphatases in the egg extract will result in accumulation of phosphorylated DUE-BSf9. This 
result has two implications. First, both endogenous kinase activity and phosphatase activity 
towards DUE-BSf9 exist in G1 phase egg extract. Second, the kinase activity and phosphatase 
activity counteract each other and keep an equilibrium (Figure 26C). 
DDK and PP2A control DUE-B phosphorylation in G1 phase egg extract 
Since the equilibrium between kinase and phosphatase keeps the unique distribution of 
DUE-BSf9 as presented in Figure 22C, any inhibition of the kinase or phosphatase activity is 
expected to shift the balance and introduce changes in DUE-BSf9 distribution. Based on this idea, 
we were able to identify DUE-B regulating kinase and phosphatase by studying DUE-BSf9 
distribution after incubating the egg extract with different inhibitors.  
We first tested the protein phosphatase 2A (PP2A) inhibitor okadaic acid (OKA). Inhibition 
of PP2A is the sole mechanism for inhibition of replication in egg extracts (Chou, Petersen et al. 
2002). In the presence of OKA, only 9 percent of total DUE-BSf9 was retained in the high 
molecular weight complexes (Figure 27A and 27B). To our surprise, OKA has higher efficiency 
in releasing DUE-BSf9 from high molecular weight complexes than the phosphatase inhibitor 
cocktail, which suggests PP2A could be the primary phosphatase that dephosphorylates DUE-B. 
To ascertain whether DUE-BSf9 release from high molecular weight complexes is a result of 
kinase activity in the absence of PP2A, a non-hydrolyzable ATP analog, AMP-PNP, was added 
into the reaction together with OKA. AMP-PNP will inhibit all the kinases and should help retain 
DUE-BSf9 in the high molecular weight complexes. As expected, adding AMP-PNP completely 
reversed the effect of OKA. Together, these results suggest PP2A is the phosphatase that 
dephosphorylates DUE-B and is essential for the high molecular weight complexes formation.   
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Figure 26. High molecular weight complex formation is a result of phosphatase activity.  
(A) DUE-BSf9 was incubated with untreated G1 phase egg extract. (B) G1 phase egg extract was 
incubated with phosphatase inhibitor cocktail for 10 minutes before DUE-BSf9 was added. DUE-
BSf9 was then incubated with egg extract for 30 minutes. (C) Schematic of the equilibrium 
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Figure 27. High molecular weight complex formation is greatly inhibited by okadaic acid.  
(A) DUE-BSf9 was incubated with G1 phase egg extract. (B) Protein phosphatase 2A specific 
inhibitor, okadaic acid, was incubated with G1 phase egg extract for 10 minutes. DUE-BSf9 was 
incubated with okadaic acid treated extract for 30 minutes. (C) AMP-PNP was added into okadaic 
acid treated G1 phase egg extract as mentioned in (B) to inhibit all kinases present in egg extract. 
DUE-BSf9  was then incubated with the okadaic acid treated egg extract supplemented with AMP-








Knowing that PP2A was able to dephosphorylate DUE-B proficiently, we kept using OKA 
as the phosphatase inhibitor in all the later experiments to avoid potential off target effects from 
phosphatase inhibitor cocktail. Inhibition of PP2A accumulates the kinase effect towards DUE-
BSf9, which could produce more pronounced effect if the kinase activity is inhibited when testing 
kinase inhibitors. A series of kinase specific inhibitors was tested, among which the DDK specific 
inhibitor PHA-767491 presented the strongest inhibitory effect towards DUE-BSf9 
phosphorylation. As shown in Figure 28A and 28B, PHA-767491 completely restored the level of 
DUE-BSf9 in high molecular weight complexes that was diminished in the presence of OKA. 
PHA-767491 is a Cdc7 specific inhibitor that can block DNA replication and inhibit Mcm4 
phosphorylation in Xenopus egg extracts (Montagnoli, Valsasina et al. 2008; Gambus, Khoudoli 
et al. 2011). Suppressing the effect of OKA by PHA-767491 suggest that Cdc7 kinase is involved 
in controlling DUE-BSf9 phosphorylation in G1 phase egg extract.  
Besides the Cdc7 inhibitor, the Cdk2 inhibitor p27 and the CKII inhibitor 4,5,6,7- 
tetrabromo-2-azabenzimidazole (TBB) were also tested using the same experiment setup. p27 can 
efficiently inhibit Cdk2 activity (Figure 18) but was not able to restore DUE-BSf9 in high 
molecular weight complexes in OKA treated egg extract (Figure 29C). This result suggests that 
although Cdk2 can phosphorylate DUE-B in vitro, it is not an active kinase in G1 phase egg 
extract that regulates DUE-BSf9 phosphorylation.  
Strikingly, CKII inhibitor TBB showed no effect in reestablishing DUE-BSf9 in high molecular 
weight complexes in the presence of OKA (Figure 29B). We have shown that CKII might be one 
of the kinases that release DUE-BSf9 from the high molecular weight complexes in G1 phase egg 
extract (Figure 25B). The reason that TBB was not sufficient to restore DUE-BSf9 in high 
molecular weight complexes could be similar to the situation of Cdk2 that CKII is not an active 
kinase in G1 phase egg extract. But another possible explanation emerged after analyzing the 
conserved phosphorylation sites on DUE-B amino acid sequence. Two classes of conserved DDK 
target sequences have been identified previously (Cho, Lee et al. 2006; Montagnoli, Valsasina et  
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Figure 28. Inhibition of Cdc7 by PHA-767491 is able to cancel the effect of okadaic acid and 
bring Sf9-DUE-B into the high molecular weight complex.  
(A) DUE-BSf9  was incubated with okadaic acid treated G1 phase egg extract for 30 minutes. (B) 
PHA-767491 was added into okadaic acid treated G1 phase egg extract to inhibit Cdc7 kinase 
activity. DUE-BSf9  was then incubated with the okadaic acid and PHA-767491 treated egg 
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Figure 29. Inhibition of CKII by TBB or inhibition of Cdk2 by p27 is not sufficient to 
antagonize the effect of okadaic acid.  
(A) DUE-BSf9  was incubated with okadaic acid treated G1 phase egg extract for 30 minutes. (B) 
TBB was added into okadaic acid treated G1 phase egg extract to inhibit casein kinase activity. 
DUE-BSf9  was then incubated with the okadaic acid and TBB treated egg extract for 30 minutes. 
(C) p27 was added into okadaic acid treated G1 phase egg extract to inhibit Cdk2 kinase activity. 
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al. 2006; Charych, Coyne et al. 2008). The intrinsic sites are characterized by serine or threonine 
followed by an acidic residue (aspartate or glutamate) at the +1 position (S/TD/E). The other type 
of sites consists of serine or threonine followed by a phosphoserine or phosphothreonine 
(S/TpS/pT) at the +1 position. Phosphorylation of the S/T at the +1 position by another kinase 
could prime the S/TpS/pT for DDK phosphorylation (Randell, Fan et al. 2010). 
As shown in Figure 30 there are three intrinsic and one phosphorylation-generated CKII site 
at the DUE-B C-terminus tail. Also, there are two intrinsic and two phosphorylation-generated 
DDK sites at the same region of DUE-B. Phosphorylation of Ser 196 and Ser 204 by DDK 
depends on prior phosphorylation on Ser 197 and Ser 205 by CKII respectively. As a result, 
phosphorylation of DUE-BSf9 by CKII might prime DUE-B for phosphorylation by DDK. To test 
this hypothesis, DUE-BSf9 was pre-phosphorylated using CKII in vitro as described in Figure 25. 
The CKII phosphorylated DUE-BSf9 was incubated with G1 phase egg extract supplemented with 
PHA-767491 (Figure 31). As expected, phosphorylation of DUE-BSf9 by CKII was not able to 
release DUE-BSf9 from high molecular weight complex when DDK kinase activity was inhibited. 
This result suggests that DDK might directly control DUE-B protein binding ability while CKII 
phosphorylation only facilitates DDK kinase activity towards DUE-B (Figure 31D).  
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Figure 31. CKII primes the DUE-B C-terminus for phosphorylation by DDK. 
 (A) DUE-BSf9 was incubated with G1 phase egg extract. (B) Casein kinase II phosphorylated 
DUE-BSf9  was incubated with G1 phase egg extract for 30 minutes. (C) PHA-767491 was added 
into G1 phase egg extract to inhibit Cdc7 kinase activity. Casein kinase II phosphorylated DUE-
BSf9  was then incubated with the PHA-767491 treated egg extract. (D) Schematic of how CKII 










DNA damage checkpoint response regulates DUE-B binding with other protein 
DUE-B is actively regulated by PP2A and DDK in G1 phase egg extract. Meanwhile, both 
PP2A and DDK are involved in DNA damage checkpoint responses through different 
mechanisms. We have seen that checkpoint responses can inhibit DUE-B chromatin loading in 
Xenopus egg extract (Figure 6 to Figure 12) and in human cells (Jianhong Yao, unpublished 
data). Therefore, I investigated whether the checkpoint response could control DUE-B 
phosphorylation and its ability to bind other proteins.  As described in Figure 12, dAdT was 
incubated with G1 phase egg extract to induce a checkpoint response. When DUE-BSf9 was 
incubated with dAdT treated egg extract, a significant accumulation of DUE-BSf9 in the high 
molecular weight complexes was observed (Figure 32A). To confirm that the accumulation of 
high molecular weigh complex was a direct consequence of ATR/ATM activation, caffeine was 
included in another experiment to attenuate ATM/ATR kinase activity. Consequently, caffeine 
completely reversed DUE-BSf9 accumulation in high molecular weight complexes induced by 
dAdT, which suggests that the high molecular weigh complex formation is not a result of protein-
DNA complexes formed on dAdT (Figure 32B). These results imply that checkpoint response 
triggered by DSB is able to alter DUE-B protein binding activity through modulating its 
phosphorylation level.  
DUE-BSf9 accumulation in high molecular weigh complex during checkpoint response 
depends on ATM/ATR kinase activity. As discussed before, it is possible that ATM/ATR inhibit 
the kinase that phosphorylates DUE-B (e.g. DDK) thus more DUE-BSf9 was left 
unphosphorylated during the checkpoint response. It is also possible that ATM/ATR directly 
phosphorylates DUE-B, then the phosphorylation by ATM/ATR prevents further modification 
that is necessary for DUE-BSf9 release from the high molecular weight complexes. In order to test 
these hypotheses, we used okadaic acid to augment the checkpoint response induced by dAdT in 
egg extract. OKA did not trigger the checkpoint response when incubated with the egg extract 
alone (Figure 33D). However, when incubated together with dAdT, the checkpoint response was  
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Figure 32. Checkpoint activated by dAdT greatly shifts DUE-B into high molecular weight 
complex. The dAdT induced accumulation of high molecular complex can be reversed by 
adding caffeine. 
(A) DUE-BSf9 was incubated with G1 phase egg extract. (B) Egg extract was supplemented with 
125 ug/ml dAdT 10 minutes before adding DUE-BSf9. (C) Five mM caffeine was added dAdT 








Figure 33. Okadaic acid reverses the effect of dAdT . 
(A) DUE-BSf9 incubated with G1 phase egg extract. (B) DUE-BSf9 incubated with dAdT treated 
egg extract (C) Okadaic acid was added to dA(70)-dT(70) treated egg extract as in B. DUE-BSf9 
was incubated with this extract for 30 minutes. (D) Okadaic acid facilitates checkpoint activation 










greatly increased. In these models, if ATM/ATR directly phosphorylate DUE-BSf9 in the 
checkpoint response, then OKA should enhance this process and result in more DUE-BSf9 
accumulation in high molecular weight complexes. On the contrary, adding OKA into egg extract 
cancelled the effect of dAdT on increased high molecular weight complexes formation (Figure 
33C). Although dAdT and OKA have synergistic effects on phosphorylating Chk1, they do not 
have a similar synergistic effect on DUE-BSf9 distribution. This result suggests that checkpoint 
response might inhibit the kinase that phosphorylates DUE-BSf9. However, OKA inhibited PP2A 
activity thus prevented DUE-BSf9 accumulation in high molecular weight complexes even if the 
kinase activity that moves DUE-BSf9 into dimer was completely inhibited. 
Summary 
DUE-BSf9 was spontaneously incorporated into high molecular weight complexes when 
incubated with G1 phase egg extract. This phenomenon resembles the endogenous DUE-B in M 
phase of the cell cycle. We utilized this unique property of DUE-BSf9 to study the effect of 
phosphorylation on high molecular weight complexes formation. We first identified only 
dephosphorylated DUE-B is incorporated in the high molecular complex. The balance of kinase 
and phosphatase activity controls DUE-B binding with other proteins. This equilibration was 
successfully used to screen a series of kinase and phosphatase inhibitors and resulted in 
identifying DDK, CKII and PP2A as the major kinases and phosphatase regulating DUE-B 
phosphorylation in G1 phase egg extract.   
In an effort to test if global kinase inhibition would affect DUE-BSf9 binding to other 
proteins, AMP-PNP was supplemented with G1 phase egg extract. 5mM AMP-PNP efficiently 
inhibited ATR kinase activity towards Chk1 during the checkpoint response (Figure 34C). 
However, no significant change of DUE-B distribution was observed (Figure 34B). We 
hypothesized that AMP-PNP can also inhibit phosphatase activity. Because phosphatase needs to 
bind to and hydrolyze the phospho group on phosphorylated amino acid residue, there is a chance 
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Figure 34. Adding AMP-PNP to egg extract did not change the distribution of DUE-BSf9.  
(A) DUE-BSf9 was incubated with G1 phase egg extract. (B) Egg extract was supplemented with 
5 mM AMP-PNP 10 minutes before incubated with DUE-BSf9. (C) Increasing concentrations of 










that binding the non-hydrolyzable phospho group on the AMP-PNP eradicates the phosphatase 
activity. This idea was later proven true in a very recent study showing that AMP-PNP greatly 
inhibited protein phosphatase 1 as well as PP2A phosphatase activity (Lin, Lin et al. 2012). This 
result suggested our assay could accurately reflect the balance of kinase and phosphatase activity 
that regulates DUE-BSf9 phosphorylation. 
VI. MCM 2-7 is part of the high molecular weight complexes 
High molecular weight complex formation correlates with inhibition of DNA replication in 
Xenopus egg extract. Inhibition of DNA replication is proportional to the dose of DUE-BSf9 
incubated with the egg extract. It is possible that DUE-BSf9 decreased the effective concentration 
of other replication factors by forming high molecular weight complexes with them. We have 
shown in the previous sections that phosphorylation on DUE-B actively regulates the high 
molecular weight complexes formation. We were therefore curious to identify the other protein 
factors that bind to DUE-BSf9 in the high molecular weight complexes. 
DUE-BSf9 binds to many proteins in high molecular weight complexes 
In order to identify DUE-B interacting proteins in high molecular weight complexes, we 
fractionated G1 phase egg extract incubated with or without DUE-BSf9 using the gel filtration 
column. Fractions containing DUE-BSf9 in the high molecular weight complexes were combined 
and DUE-BSf9 was isolated together with other interaction proteins using Ni-NTA agarose. The 
exact same procedure was carried out on the sample without DUE-BSf9. The Ni-NTA agarose 
bead bound proteins from both samples were sent out for MALDI-TOF mass spectrometry 
analysis at the Ohio State University Proteomics Facility. Protein fragments were identified using 
the MASCOT peptide mass fingerprint algorithm. A total of 282 proteins were identified from 
egg extract incubated with DUE-BSf9. Many proteins were also found from samples without 
DUE-BSf9. By subtracting the same hits present in both samples, a list of proteins that are unique 
in the sample incubated with DUE-BSf9 was obtained. Several potentially interesting proteins with 
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highest protein score were listed in Table 1. Surprisingly, many RNA binding proteins and all 6 
subunits of the MCM2-7 complex were detected as DUE-BSf9 binding partners. 
It has been shown that DUE-B is the only mammalian protein showing sequence or 
structural homology to the bacterial DTD1 proteins and it maintains the D-aminoacyl tRNA 
deacylase activity as its orthologs in lower organisms. It is possible that a fraction of DUE-B was 
still executing the tRNA proofreading function and was co-purified with other RNA binding 
proteins in this pull down assay. Of most interest, no one has shown that DUE-B binds the 
MCM2-7 complex in the cell.  
DUE-B and Mcm3/5 co-immunoprecipitate with each other 
Protein co-immunoprecipitation technique was introduced to confirm the interaction of 
DUE-B and the MCM2-7 complex identified in mass spectrometry. DUE-B specific antibody 
coupled with protein G beads was used to pull down DUE-BSf9 incubated in G1 phase egg extract 
in order to differentiate from the Ni-NTA agarose utilized in mass spectrometry analysis. In pilot 
experiments, all rabbit antisera (normal rabbit serum, WRSU1 and WRSU7) showed strong 
nonspecific binding to all the MCM2-7 subunits tested (data not shown). We reasoned this 
background binding could be a result of the impurities in the antisera because normal rabbit 
serum showed the high level of MCM co-IP signal that is resistant to stringent salt and detergent 
wash. So we carried out antibody affinity purification using purified recombinant DUE-B. As 
shown in Figure 35, 5 mg recombinant DUE-B was obtained from 9 liters BL21 culture. 
Concentrated proteins were separated on SDS-PAGE and transferred to nitrocellulose membrane. 
The DUE-B band was excised out to clear out contaminating proteins then WRSU7 antiserum 
was incubated with membrane bound DUE-B. Anti-DUE-B IgG was eluted from membrane 
using pH 2.0 glycine buffer followed by immediate neutralizing to pH 7.4.  
Purified DUE-B antibody but not normal rabbit IgG could efficiently pull down DUE-BSf9 
from Xenopus egg extract as well as Mcm3 and Mcm5 subunits (Figure 36). Consistently,  
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Table 1. Mass spectrometry analysis of Xenopus proteins binding to DUE-BSf9 in the high 
molecular weight complex. 
DUE-B interacting proteins were pulled down with 6xHis-tagged DUE-BSf9 using Ni-NTA 
agarose beads from fractions containing high molecular weight complex. Proteins listed were 
found precipitating with Ni-NTA agarose in the egg extract incubated with 6xHis-tagged DUE-
BSf9 but not in control egg extract (xCDC46 is Xenopus Mcm5).   
 
98	  
Figure 35. WRSU7 antibody production and antibody affinity purification. 
BL21 cells were transformed with pTrc-His WTDUE-B plasmid. 3 different colonies were picked 
and induced for protein expression by 1 mM IPTG. 6xHis tagged DUE-B was purified using Ni-
NTA column and the protein concentration was determined by comparing with BSA standard on 
silver stain. 5 mg purified DUE-B was subjected to SDS-PAGE and transferred to nitrocellulose 
membrane. DUE-B antibody was affinity purified by binding to the fixed DUE-B on the 





Figure 36. Xenopus Mcm3 and Mcm5 co-IP with DUE-BSf9 in G1 phase egg extract.  
(A) Co-immunoprecipitation (co-IP) of Xenopus egg extracts incubated with DUE-BSf9 using 
normal rabbit IgG or affinity purified DUE-B antibody. Purified DUE-B antibody or normal 
rabbit IgG were conjugated with protein G beads and then incubated with egg extract in 4 °C for 
5 hours with continuous rotation. Beads bound proteins were washed 5 times with TBST (20 
mM Tris pH 7.6; 154 mM NaCl; 0.1% Tween-20), JY+100 mM NaCl (20 mM Hepes pH 7.4; 
0.5 % Triton X-100; 250 mM NaCl; 1.5 mM MgCl; 2 mM EGTA; 10mM NaF; 2 mM DTT; 1 
mM NaVO4; 1 mM PMSF; 20 µM aprotinin) or RIPA (50 mM Tris pH 8; 150 mM NaCl; 1% 
NP-40; 0.5% sodium deoxycholate; 0.1% SDS). Beads were then boiled in Western blot sample 
buffer. Proteins were analyzed using specific antibodies. (B) Co-Immunoprecipitation (co-IP) of 
Xenopus egg extracts incubated with DUE-BSf9 using normal mouse IgG, Mcm3 or Mcm5 
antibody. Normal mouse IgG, Mcm3 or Mcm5 antibody were conjugated with protein G beads 
and then incubated with egg extract in 4 °C for 5 hours with continuous rotation. Beads bound 
proteins were washed 5 times with EB (50mM KCl; 50mM Hepes pH 7.6; 5mM MgCl2) or 
JY+100mM NaCl+ 50mM KCl (20 mM Hepes pH 7.4; 0.5 % Triton X-100; 250 mM NaCl; 1.5 
mM MgCl; 2 mM EGTA; 10mM NaF; 2 mM DTT; 1 mM NaVO4; 1 mM PMSF; 20 µM 
aprotinin; 50mM KCl). Beads were then boiled in Western blot sample buffer without beta 
mercaptoethanol. Protein was detected using purified DUE-B antibody. 
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DUE-BSf9 was able to co-IP with either Mcm3 or Mcm5 reciprocally. Co-IP results confirmed the 
finding by mass spectrometry that DUE-BSf9 is able to interact with MCM2-7 subunits in Xenopus 
egg extract. We also tested the interaction between DUE-BSf9 and Mcm7 but no significant co-IP 
was observed (data not shown). We cannot completely rule out the possibility that the washing 
conditions used for Mcm7 co-IP experiments were not optimized. However, it is reasonable to 
conclude that DUE-BSf9 binds to MCM2-7 in the high molecular weight complexes through 
interaction with at least some of the MCM subunits. 
DUE-B forms more than one high molecular weight complexes in Xenopus egg extract 
 Mass spectrometry data indicated that DUE-BSf9 is interacting with other RNA binding 
proteins in high molecular weight complexes. I hypothesized that DUE-BSf9 and other RNA 
binding proteins all bind to RNA molecules resulting in the formation of high molecular weight 
complexes (Lee, Cho et al. 2004). To test this hypothesis, DUE-BSf9 was incubated with G1 phase 
egg extract treated with 840,000 units RNase A/mL. A significant change in DUE-BSf9 
distribution was observed in egg extract treated with RNase A (Figure 37B). As expected RNase 
treatment resulted in decreasing of DUE-BSf9 in the high molecular weight complexes suggesting 
that RNA acted as backbone supporting some of the high molecular weight complexes formation. 
Interestingly, an RNase resistant peak of DUE-BSf9 was detected in a smaller high molecular 
complex with apparent molecular weight of 700 kD. Coincidentally, this RNase resistant peak of 
DUE-BSf9 perfectly overlapped with Mcm7 complex, which is consistent with previous finding 
that DUE-BSf9 co-IP with MCM2-7 complex in egg extract. We then tested if this 700kD high 
molecular weight complex is subjected to kinase/phosphatase regulation as in previous 
experiments. DUE-BSf9  was incubated in G1 phase egg extract treated with OKA in the presence 
of RNase. Consistently, the 700kD protein complex was also sensitive to OKA treatment (Figure 
37C). Therefore, phosphorylation controls both the 700 kD and the 4000 kD high molecular 
weight complexes formation.  
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Figure 37. DUE-B forms more than one high molecular complex in egg extract.  
(A) DUE-BSf9 was incubated with G1 phase egg extract. (B) 600 ug RNase was incubated with 
50 ul G1 phase egg extract for 30 minutes. DUE-BSf9 was then incubated in this treated extract 
for 30 minutes. (C) Okadaic acid was supplemented in the RNase treated egg extract then 










We used mass spectrometry to show that DUE-B co-purifies with the MCM2-7 complex and 
many RNA binding proteins. Co-IP experiments confirmed the interaction between DUE-B and 
Mcm3 and Mcm5. By incubating DUE-BSf9 with RNase treated egg extract, we found that DUE-
BSf9 was incorporated into at least two different high molecular weight complexes in G1 phase 
egg extract. Interestingly, one of the high molecular weight complexes requires RNA while the 
other one has a distribution overlapping perfectly with Mcm7. Phosphorylation of DUE-B is a 
shared mechanism releasing DUE-B from both high molecular weight complexes. Together, this 
diversity of DUE-B high molecular weight complexes formation is consistent with the mass 
spectrometry result that DUE-B binds to both RNA binding proteins and MCM2-7 complex. 
More importantly, the existence of different high molecular weight complexes potentially reflects 
DUE-B is a multifunctional protein that acts in both RNA proofreading and DNA replication 
initiation.  
VII. Phosphorylation at the C-terminus is important for regulating the activity of DUE-B 
In previous chapters, we have shown that phosphorylation of DUE-B is an important way of 
regulating its function. The evidence provided by this study or from previous lab members all 
suggest that the C-terminus tail is very important for the regulation of DUE-B function. The N-
terminus of DUE-B is highly conserved throughout evolution as the D-aminoacyl tRNA 
deacylase. However, DUE-B acquired about 60 amino acids at the C-terminus tail in higher 
organisms. Multiple sequence alignment reveals that the amino acid sequence in the C-terminus 
tail is highly conserved during evolution suggesting the potential importance of the C-terminal 
tail. The C-terminus tail is especially rich in serine and threonine residues (14 out of 60 aa), many 
of which are conserved sites for kinases regulating cell cycle progression. The DUE-B C-
terminus tail is structurally disordered (Kemp, Bae et al. 2007) which renders it a favorable 
domain for protein-protein interaction or post translational modification (Iakoucheva and Dunker 
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2003). Evidently, the C-terminus truncated DUE-B has very distinct property compared with the 
wild type DUE-B (Figure 11). Also, we have shown that DUE-B is regulated by CKII, DDK and 
hypothesized these kinases phosphorylate DUE-B at the C-terminal domain (Figure 30). Here, we 
provide more information on how the DUE-B C-terminus domain regulates its function. 
C-terminus domain regulates DUE-B subcellular localization 
In order to study the function of the DUE-B C-terminus domain, a C-terminus 60 amino acid 
deletion mutant (ΔCT DUE-B) was generated. Both WT DUE-B and ΔCT DUE-B were cloned 
into pEYFPC1 plasmid in which the YFP tag was attached to the N-terminus of DUE-B and the 
protein expression was driven by CMV promoter (appendix 8). HeLa cells were transfected with 
either vector with Lipofectamine 2000. Thirty-six hours after transfection, cells were fixed with 
2% paraformaldehyde, stained with DAPI and visualized under the fluorescent microscope. 
Interestingly, YFP WT DUE-B and YFP ΔCT DUE-B showed significant differences in 
subcellular localization (Figure 38A). WT DUE-B located in both the nucleus and cytoplasm. 
There was more WT DUE-B in the cytoplasm than that in the nucleus with exception in M phase 
cells when the nuclear envelope breakdown. On the contrary, YFP ΔCT DUE-B preferentially 
localized in the nucleus as indicated by most YFP signal merges with DAPI signal. In order to 
prove that the difference in YFP subcellular localization was not from protein degradation, whole 
cell lysates from cells used in Figure 38A were subjected to Western blotting using anti GFP 
antibody. Western blot result showed no sign of protein degradation (Figure 38B). So we 
conclude that YFP signal in Figure 38A truly reflected the subcellular localization of DUE-B 
mutants. Consistent with this finding, when cells transfected with YFP WT DUE-B were 
fractionated into cytoplasm and nucleus fractions, both YFP WT DUE-B and endogenous DUE-B 
were found mostly in the cytoplasm fraction (Figure 38C). However, in another cell fractionation 
experiment, we saw ΔCT DUE-B preferentially located in the chromatin bound fractions 
(Jianhong Yao unpublished result). These results suggest that DUE-B C-terminus  
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Figure 38. ΔCT DUE-B has different sub-cellular localization from the WT DUE-B.  
(A) HeLa cells expressing YFP-WT DUE-B or YFP-ΔCT DUE-B were fixed with 2% 
paraformaldehyde, stained with DAPI and visualized under the fluorescent microscope. (B) 
Whole cell lysate from (A) were analyzed by Western blot probed using rabbit anti GFP 
antibody  (C) HeLa cells transfected with YFP-WT DUE-B was fractionated into cytoplasm 
(Cyto) and nucleus (Nu) fractions. Proteins were detected using rabbit anti DUE-B antibody. (D) 
Using the online nuclear localization signal prediction tool developed by Kosugi et al., (2009), a 
low strength NLS was detected at the N-terminus (23-51 aa) region of DUE-B (labeled in red). 
(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi) 
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domain is involved in controlling DUE-B subcellular localization. Using the online nuclear 
localization signal prediction tool developed by Kosugi et al., (2009), a low strength NLS was 
detected at the N-terminus (23-51 aa) region of DUE-B (Figure 38D). It is possible that the C-
terminus domain controls DUE-B binding with other proteins that keeps most of DUE-B outside 
of the nucleus by shielding the NLS inside of the protein complex. It is also possible that the C-
terminus domain is in complex with other protein(s) containing a strong nuclear export signal. 
In order to study the function of the DUE-B C-terminus domain in protein binding activity, 
we synthesized WT DUE-B and ΔCT DUE-B using an in vitro translation system (IVT). WT 
DUE-B and ΔCT DUE-B synthesized using the IVT system were incubated with G1 phase egg 
extract separately. As shown in Figure 39A, there were two peaks containing WT DUE-BIVT 
fractionated with the gel filtration column, which resembles the distribution of DUE-BSf9. In 
contrast, when ΔCT DUE-BIVT was incubated with egg extract, the DUE-B signal from high 
molecular weight complexes dramatically decreased, suggesting a potential deficiency in binding 
with other proteins. Interestingly, deletion of the C-terminus 60 amino acids did not completely 
abolish the high molecular weight complexes formation. There was still 12% total ΔCT DUE-
BIVT left in the protein complexes bigger than DUE-B dimer. The incomplete loss of protein 
binding ability of ΔCT DUE-BIVT indicates that the C-terminus domain could be regulating DUE-
B interacting with other protein in high molecular weight complexes rather than a direct 
interacting domain.  
Phosphorylation at DUE-B C-terminus is critical for DNA replication and cell growth 
Previous results from Xenopus egg extract suggested that phosphorylation of DUE-B 
regulates its activity. The DUE-B C-terminus domain is very rich in serine and threonine and 
contains many conserved target sites for every kinase identified in this study (Figure 30). In order 
to study the physiological function of DUE-B C-terminus phosphorylation, point mutants 
targeting the C-terminus phosphorylation sites and C-terminus deletion mutant were generated 
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(Figure 40). In the S/T-A mutants (STA DUE-B), 8 serine or threonine residues at the very end  
Figure 39. IVT translated DUE-B lacks the modification that keeps endogenous DUE-B in 
the dimer form.  
 (A) WT-DUE-BIVT incubated with G1 phase egg extract for 30 minutes. (B) ΔCT DUE-BIVT 
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Figure 40. DUE-B C-terminus domain mutants. 
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of the DUE-B C-terminus were mutated to non-phosphorylatable alanine. In the S/T-D mutants 
(STD DUE-B), the serine or threonine residues mutated in STA DUE-B were changed to 
phospho-mimetic aspartate to simulate the phosphorylated residues. These mutants were assayed 
in both Xenopus egg extract and cultured human cells.  
Different DUE-B mutants were cloned into pcDNA3.1 plasmid in which the protein 
expression is driven by the CMV promoter (appendix 8). HeLa cells were transfected with 
different DUE-B mutants separately under the same condition. Twenty-four hours after 
transfection, cells were re-plated into a new 6 well plates with concentration of 2000 cells /well 
and grown under G418 selection for 16 days. Surprisingly, only cells expressing STA DUE-B 
showed severe growth defect (Figure 41A). To understand the reason for the dominant inhibition 
of cell growth even in the presence of endogenous DUE-B, whole cell lysate was prepared from 
the transfected cells. Western blot showed increased phosphorylated Chk1 level in cells 
expressing STA DUE-B suggesting the DNA replication checkpoint was activated in these cells 
(Figure 41 B). The activation of checkpoint was probably due to abnormal DNA replication in 
these cells. We then used flow cytometry to analyze the DNA content of these cells expressing 
different DUE-B mutants (Figure 42). HeLa cells expressing WT DUE-B had the same DNA 
content profile as those expressing ΔCT DUE-B. However, cells overexpressing STA mutant 
showed a slightly increased amount of cells in S phase and less cells in G1 and M phase of the 
cell cycle. This result suggests that the STA DUE-B mutant might be able to interfere with DNA 
replication. As a result, it takes more time for cells to progress through S phase and activates 
checkpoint response.  
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Figure 41. Phosphorylation of C-terminus S/T residues is important for cell grow.  
(A) Equal numbers of HeLa cells were transfected with same amount of pcDNA3.1 plasmid 
carrying different DUE-B mutants using the same transfection condition. 24 hour after 
transfection, cells were re-plated into a new 6 well plates with concentration of 2000 cells /well. 
Diluted cells were kept under G418 selection for 16 days after transfection. Cell culture media 
were changed with fresh media containing G418 every 2 days. Cells were stained with crystal 
violet and washed with water. HeLa cells transfected with S/T-A DUE-B mutant showed severe 
defect in colonies forming. Cells transfected with other DUE-B mutant or WT DUE-B formed 
colony normally. (B) Transfected HeLa cells left from A were plated in 10 cm plates and were 
grown in complete medium containing G418 for 5 days. Then total proteins were subjected to 
SDS-PAGE. DUE-B mutant expression was examined with DUE-B anti-serum and checkpoint 







Figure 42. S/T-A mutant induces slight increasing in sub G1 and S phase cells in 
asynchronous population.  
Equal numbers of HeLa cells were transfected with same amount of pcDNA3.1 plasmid carrying 
different DUE-B mutants using the same transfection condition. 48 hours after transfection, cells 
were trypsinized and stained with propidium iodide after RNase digestion. DNA content was 
analyzed using Accuri C6 flow cytometer. (A) DNA profile from cells transfected with WT 
DUE-B was overlapped with cells transfected with ΔCT DUE-B. (B) DNA profile from cells 
transfected with WT DUE-B was overlapped with cells transfected with STA DUE-B. (C) 
Percentage of cell population in each phase of the cell cycle from three samples. 
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In order to study the direct effect of DUE-B phosphorylation on DNA replication, we 
purified DUE-B mutants from HeLa cells and added those proteins into egg extract. Sperm 
chromatin was replicated in Xenopus egg extract pre-incubated with WT, ΔCT or STA DUE-B 
purified from transfected HeLa cells in the presence of α-[32P]-dCTP. After electrophoresis of the 
replication product and autoradiography, a significant inhibition of DNA replication was detected 
in egg extract pre-incubated with STA DUE-BHeLa but not samples incubated with WT or ΔCT 
DUE-BHeLa (Figure 43). This provided direct evidence that phosphorylation at the DUE-B C-
terminus domain is essential for DNA replication initiation and that the presence of full-length, 
nonphosphorylatable DUE-B exerts a dominant negative effect on DNA replication. 
Due to the difficulty of purifying enough relatively pure proteins from HeLa cells, especially 
for the STA DUE-B mutant, we synthesized DUE-B mutants in vitro using Thermo Scientific 
Human In Vitro Protein Expression Kit. All four DUE-B constructs were generated and were 
incubated with G1 phase egg extract.  
Sperm chromatin was replicated in egg extracts pre-incubated with DUE-B mutants in the 
presence of 0.1 uCi/ul α-[32P]-dCTP. Egg extract supplemented with in vitro translated GFP and 
recombinant p27 were included as untreated and negative controls, respectively. Replicated DNA 
was separated on a 0.8% agarose gel and exposed to X-ray film. Replication was measured as the 
amount of 32P incorporation. All DUE-B mutants produced in IVT system inhibited DNA 
replication to some extent as compared with the GFP control suggesting that DUE-B mutants 
synthesized in vitro lack necessary posttranslational modification important for DNA replication 
initiation (Figure 44). This is a property shared by both DUE-BSf9 and DUE-BIVT. Strikingly, egg 
extract incubated with ΔCT DUE-B and STD mutants presented the most severe inhibition of 
DNA replication. On the contrary, STA mutants showed the least replication inhibition among all 
samples. The effects presented using in vitro synthesized proteins were opposite to those 
identified using proteins purified from HeLa cells. This dramatic difference provided more 
insights into the importance of posttranslational modification in affecting DUE-B’s physiological  
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Figure 43. S/T-A DUE-B purified from HeLa cells dominantly inhibited DNA replication 
when added into Xenopus egg extract. 
WT DUE-B and ΔCT DUE-B was purified from established cell line overexpressing 6xHis 
tagged WT DUE-B or 6xHis tagged ΔCT DUE-B. S/T-A DUE-B was purified from cells 
transiently expressing 6xHis tagged S/T-A DUE-B after transfection. The same amount of protein 
was incubated with G1 phase egg extract containing 0.1 uCi/ul α-[32P]-dCTP for 10 minutes 
before adding sperm chromatin. Sperm chromatin was replicated in egg extract for 90 minutes 
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Figure 44. Phosphorylation of C-terminus of DUE-B regulates its activity in DNA 
replication initiation.  
(A) Different mutations of DUE-B synthesized in vitro was incubated in G1 phase egg extract 
containing 0.1 uCi/ul α-[32P]-dCTP 10 minutes before sperm chromatin was added. DNA samples 
were collected at 90 minutes after adding sperm chromatin and analyzed by electrophoresis and 
autoradiography. 32P was used as indication of DNA replication. (B) Sperm chromatin replication 
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function. It is possible in vitro synthesized DUE-B mutants carried certain posttranslational 
modification that made the N-terminus inhibitory to DNA replication in Xenopus egg extract. 
When the C-terminus domain was not phosphorylated as in STA mutant, it negatively regulated 
the N-terminus inhibitory effect thus allowed DNA replication. On the other hand, the STD 
mutant mimicked the phosphorylated state of the C-terminus tail and fully exposed the N-
terminus inhibitory effect. Phosphorylation at the C-terminus domain acted as a switch controls 
the function of N-terminus. However, more study is needed to understand why in vitro 
synthesized ΔCT DUE-B inhibits DNA replication and the potential relevance of this phenotype 
to its function in vivo. 
Previous research showed that the C-terminus domain is highly disordered and not 
crystallizable. Structural prediction by DisEMBL program was used to understand the potential 
implication of C-terminus phosphorylation on the C-terminus disorder. Consistently, the C-
terminus domain of WT DUE-B is predicted to be highly disordered. STD DUE-B shared a 
similar level of disorder at the C-terminus tail as the WT DUE-B. However, the STA DUE-B is 
less disordered in the same region (Figure 45). The disordered C-terminus might be able to bind 
other proteins as well as fold back on the N-terminus. This result suggests that dephosphorylation 
of the DUE-B C-terminus domain might change the protein structure and result in different 
function in supporting DNA replication. This prediction supports the finding that STA DUE-B 
showed the most difference in function from the WT DUE-B while STD DUE-B resembles the 
property of the WT DUE-B in every assay we tested.   
Summary 
The DUE-B C-terminus domain is rich in serine and threonine and is a target for Cdk2 and 
CKII in vitro. In this research, we provided evidence that the C-terminal phosphorylation is 
important for cell growth potentially through regulating DNA replication. The C-terminus domain 
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can control DUE-B subcellular localization and its activity in DNA  
Figure 45. Dephosphorylating of DUE-B C-terminus decreases the level of disorder at the 
C-terminus.  
The DUE-B amino acid sequence was analyzed using the DisEMBL program to predict the 
disordered region of the protein. (http://dis.embl.de/) WT DUE-B was plotted together with DUE-
B mutants generated in this study. Dashed yellow line is the predicted threshold of disorder. 
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replication. Surprisingly, DUE-B synthesized from different sources presented totally different 
abilities in regulating DNA replication suggesting DUE-B synthesized in vitro acquired an 
additional ability to inhibit DNA replication, possibly through posttranslational modifications. 
Nevertheless, the ability of regulating the protein function by C-terminus phosphorylation is 
shared among all DUE-B proteins tested in this study. Structural prediction also suggests 
phosphorylation would possibly change the protein structure of the C-terminus domain. Further 
study is needed to understand the detailed mechanism of this regulation. 
	    
119	  
DISCUSSION 
By using the human c-Myc replication origin DNA unwinding element as bait, our lab screened a 
human protein expression library and identified the DNA Unwinding Element Binding protein 
(DUE-B) as an essential DNA replication initiation factor in higher organisms. As a replication 
protein, DUE-B needs to be tightly regulated during the cell. The data presented here provided 
insight into how DUE-B is regulated in the cell during replication initiation and the checkpoint 
response. In particular, this study recognized phosphorylation as an important factor controlling 
DUE-B function in many cellular events.  
I. DUE-B is an essential replication factor required for Cdc45 chromatin binding 
DUE-B was identified as a replication origin binding protein and later proven to be an 
essential replication initiation factor. Previous research showed that the Origin Recognition 
Complex (ORC) is necessary for DUE-B chromatin loading and Cdc45 chromatin binding was 
inhibited without DUE-B in HeLa cells. In this study, we used the Xenopus egg extract system to 
confirm the result that DUE-B is necessary for Cdc45 chromatin loading. Additionally, we 
identified TopBP1 as another replication factor that is inhibited in the absence of DUE-B (Figure 
4). This result suggests that DUE-B is involved in a step before both Cdc45 and TopBP1 
chromatin loading. We also proved that DUE-B chromatin loading depends on MCM loading and 
CDK kinase activity, which narrows down the timing of DUE-B loading to a point after pre-RC 
formation and CDK kinase activation but before Cdc45 and TopBP1 chromatin loading (Figure 2 
and 3).  
Prior studies from yeast and the Xenopus egg extract system suggested that the major result 
of CDK activation during DNA replication initiation is to activate the MCM helicase by loading 
Cdc45 onto the replication origin. In yeast, the most important step between CDK activation and 
Cdc45 loading is phosphorylation of Sld2 and Sld3 (Labib 2010). Phosphorylated Sld2 and Sld3 
interact with Dpb11 and load Cdc45 onto the replication origin (Tanaka, Umemori et al. 2007; 
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Zegerman and Diffley 2007). However, the identity of the Sld3 ortholog in higher organisms is 
still under debate.  
Since the timing of DUE-B chromatin loading resembles that of yeast Sld3 and is also 
essential for Cdc45 loading, we speculated that DUE-B might share some properties with Sld3. 
Using co-immunoprecipitation method, we showed that DUE-B, Cdc45 and TopBP1 interact with 
each other in asynchronous HeLa cells and when over expressed in insect cells (Chowdhury, Liu 
et al. 2010). This result suggests DUE-B could be involved in Cdc45 and TopBP1 chromatin 
binding by directly interacting with them. However, interactions among endogenous proteins are 
not detected in highly synchronized G1 phase egg extracts. This discrepancy suggested that 
strong interactions among these three proteins at physiological concentration might be restricted 
to DNA replication initiation and potentially rely on high level of CDK and DDK activity during 
the S phase of the cell cycle. Similarly, the formation of many protein complexes necessary for 
pre-IC formation has been shown to depend on CDK and DDK kinase activity. Studies in 
budding and fission yeast showed that the interaction between Sld2 (Drc1), Sld3 and Dpb11 
(Cut5) requires CDK kinase activity (Zegerman and Diffley 2007; Fukuura, Nagao et al. 2011). 
Also, formation of the preloading complex containing DNA polymerase ε, GINS, Sld2, and 
Dpb11 also requires the CDK kinase activity (Muramatsu, Hirai et al. 2010). Like the yeast Sld3, 
we found that Cdk2 phosphorylates DUE-B in vitro at threonine 187 residue while serine 147 is 
only minimally phosphorylated (Figure 15 to Figure 18). This phosphorylation could be essential 
for the interaction of DUE-B, Cdc45 and TopBP1. More studies are required to test the 
physiological significance of this phosphorylation event.  
Consistent with its role in Cdc45 loading, DUE-B chromatin loading precedes RPA 
chromatin binding, which is dependent on MCM activation. Interestingly, DUE-B does not stay 
on the chromatin after DNA replication initiation nor does it move with the replication fork 
(Figure 1B). When comparing the signal intensity between proteins, a significantly less amount of 
DUE-B can be detected on chromatin during replication initiation despite the fact that DUE-B 
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presented strongest signal in the positive control (Figure 1A). These results suggest that rather 
than a part of the moving replication fork, DUE-B might serve as a protein loader that carries 
Cdc45 and TopBP1 onto the replication origin. Noticing there is only a small fraction of DUE-B 
localized in the nucleus (Figure 38A and 38C), DUE-B could be released from one specific 
replication origin after Cdc45 and TopBP1 loading and then gets recycled to load other Cdc45 
and TopBP1 onto other replication origins. Consistent with this hypothesis, DUE-B is constantly 
regulated under the equilibrium of kinase and phosphatase activity. Dephosphorylation allows 
DUE-B to bind other proteins and transport them to the origins while phosphorylation releases 
DUE-B and leave the replication factors on the origins. 
Data presented in this section can be summarized in the following model (Figure 46). In G1 
phase of the cell cycle, ORC recognizes and binds to DNA replication origins. Cdt1 and Cdc6 
together recruit the MCM 2-7 complex onto the replication origin. Later, the MCM 10 is loaded 
on to the replication origin independent of CDK and DDK kinase activity (van Deursen, Sengupta 
et al. 2012). The pre-replication complex formed in the G1 phase of cell cycle does not have 
active helicase activity. During the G1 to S phase transition, DDK and CDK kinase activity raises 
and facilitates the interaction of DUE-B, Cdc45 and TopBP1. The formation of DUE-B-Cdc45-
TopBP1 complex is restricted to the S phase of the cell cycle. After Cdc45 chromatin loading, 
DUE-B is released from the replication origin and can be reused in late origins to load Cdc45. 
However, more studies will be needed to verify that DUE-B released from one replication origin 
can be utilized again in other origins.  
Our result showed that DUE-B presents many features common with the yeast Sld3. Both 
DUE-B and Sld3 interact with Cdc45 and TopBP1. Both proteins are required for Cdc45 and 
TopBP1 chromatin loading and are substrates of CDK. Interestingly, there are two proteins 
identified from higher organisms by other groups resemble the property of yeast Sld3. Treslin and 
GEMC1 are both necessary for Cdc45 chromatin loading and DNA replication initiation. CDK 
can phosphorylate both Treslin and GEMC1 to facilitate their interaction with TopBP1 during  
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replication initiation (Balestrini, Cosentino et al. 2010; Kumagai, Shevchenko et al. 2010). All 
three proteins are attractive candidates for Sld3 ortholog in higher organisms but none of these 
proteins has significant sequence homology to Sld3. On the other hand, it is possible that Sld3 
branched out into different paths and resulted in three functional orthologs that work together in 
higher organisms. It is interesting to know whether these three proteins interact with each other in 
vivo. More research is needed to find out whether these three proteins carry out the Sld3 function 
in higher organisms. 
II. DNA replication checkpoint inhibits DUE-B chromatin binding 
DNA replication checkpoint is activated when replication is challenged. There are many 
effects after DNA damage checkpoint activation including stabilizing the existing replication 
forks, upregulating ribonucleotide reductase and inhibiting late origin firing (Zegerman and 
Diffley 2009). Although there are different signal pathways involved in the checkpoint response 
depending on the DNA damage encountered, many of them have been shown to inhibit Cdc45 
chromatin loading. Since DUE-B is involved in Cdc45 chromatin loading during replication 
initiation, we asked the question if DUE-B chromatin loading is also sensitive to checkpoint 
response.  
We tested aphidicolin, etoposide and dA(70)-dT(70), all of which have been shown to 
induce replication checkpoints and inhibit Cdc45 chromatin loading in Xenopus egg extracts 
(Chou, Petersen et al. 2002; Costanzo, Shechter et al. 2003; Yanow, Gold et al. 2003; Luciani, 
Oehlmann et al. 2004; Byun, Pacek et al. 2005; Petersen, Chou et al. 2006). However, the 
mechanisms of how checkpoint response inhibits Cdc45 chromatin binding are not completely 
understood. Models proposed by different groups do not completely agree with each other but 
they generally fall into three categories. The first category suggests that ATR/ATM activated by 
DNA damage inhibits Cdc25, which is a phosphatase necessary for CDK kinase activation. 
Inhibition of Cdc25 will block the CDK kinase activity and inhibit Cdc45 loading. The second 
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category favors the model that ATR/ATM inhibits DDK activity by phosphorylating Dbf4 or 
replacing Dbf4 with Drf1. Lastly, the third category argues that the checkpoint response inhibits 
Cdc45 chromatin loading by directly phosphorylating Sld3, independently of CDK and DDK 
kinase activity (Lopez-Mosqueda, Maas et al. 2010; Zegerman and Diffley 2010).  
Interestingly, all of the agents tested were also able to inhibit DUE-B chromatin loading. 
Because DUE-B and Cdc45 chromatin loading are closely related and potentially depend on each 
other, it is possible that DUE-B chromatin loading is regulated through the similar mechanisms as 
Cdc45. Firstly, both DUE-B and Cdc45 chromatin loading require CDK kinase activity. It is 
possible that checkpoint response inhibited CDK and caused deficiency in chromatin binding of 
both proteins. However, in an effort of testing the chromatin binding pattern of DUE-BSf9, we 
found p27 inhibited both endogenous and exogenous DUE-B chromatin binding while 
aphidicolin treatment did not have any effect on the DUE-BSf9 loading onto chromatin. This result 
provided evidence that the checkpoint response triggered by aphidicolin inhibits DUE-B 
chromatin loading independent of CDK kinase activity.  
Additionally, we tested the possibility that DUE-B is directly phosphorylated by checkpoint 
kinases in response to DNA damage. We showed that the checkpoint activated by dAdT inhibits 
DUE-BSf9 release from the high molecular weight complexes (Figure 33A). Okadaic acid is able 
to enhance the effect of ATM/ATR kinase activity on Chk1 by blocking the antagonizing PP2A 
phosphatase (Figure 33D) (Petersen, Chou et al. 2006). However, combining OKA with the dAdT 
treatment did not introduce any additional accumulation of dephosphorylated DUE-BSf9 in high 
molecular weight complexes. On the contrary, inhibition of PP2A suppressed the dAdT induced 
accumulation of DUE-B in high molecular weight complexes (Figure 33C). This result ruled out 
the possibility that the checkpoint kinase ATM/ATR activated by dAdT directly phosphorylates 
DUE-B. Instead, the checkpoint response activated by dAdT could suppress a kinase that is 
necessary for DUE-B phosphorylation. 
Another possible consequence of checkpoint activation is inhibition of DDK activity that is 
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essential for Cdc45 chromatin loading and interaction with MCM (Jares and Blow 2000; Zou and 
Stillman 2000; Masai, Taniyama et al. 2006). Remarkably, DDK is identified as a kinase involved 
in DUE-B phosphorylation. If DDK kinase activity is inhibited as a result of the checkpoint 
activation, then DUE-B phosphorylation will be blocked. It is possible that checkpoint activation 
repressed the DDK kinase activity and thus blocked both DUE-B and Cdc45 chromatin loading at 
the same time but through different mechanisms. It is equally possible that DDK kinase activity is 
only required for either Cdc45 or DUE-B chromatin loading. Since DUE-B and Cdc45 bind to 
chromatin in a coordinated manner, inhibition of either Cdc45 or DUE-B chromatin binding 
could result in deficiency in recruiting the other protein onto the replication origin. Further study 
is required to differentiate these possibilities.  
Importantly, research from other groups trying to understand the mechanism of how 
checkpoints inhibit Cdc45 chromatin loading did not result in a consistent answer. Possible 
explanation for the difference between studies could be because each individual group used 
different chemical agents to induce the checkpoint response. It is known that aphidicolin, 
etoposide and dAdT generate distinctive DNA-protein structures that would independently 
activate checkpoint responses through ATR, ATM or both pathways. It is not clear whether each 
pathway has specific effective target in regulating DUE-B and Cdc45 chromatin binding. But the 
advantage of having multiple regulating mechanisms is they could act redundantly to ensure no 
new origin firing when DNA synthesis is challenged. We could not rule out the possibility that 
DDK is inhibited in aphidicolin, dAdT and etoposide induced checkpoint response. Also, direct 
phosphorylation of DUE-B by ATR/ATM could be a result of checkpoint response triggered by 
aphidicolin and etoposide. Nevertheless, many types of DNA damage could be processed to 
similar structures in the cell and conversion between ATR and ATM pathway does exist (Shiotani 
and Zou 2009). More detailed investigation is needed to understand the exact mechanism of how 
different types of DNA damage regulate DUE-B chromatin binding. 
In addition to the effect of checkpoint response on DUE-B chromatin loading, we also 
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tested whether DUE-B is necessary for checkpoint activation. Our data clearly showed that 
neither ORC nor DUE-B is necessary for checkpoint activation in response to dAdT treatment in 
the Xenopus egg extract. Consistent with prior study, we confirmed that depletion of TopBP1 
abolished the Chk1 phosphorylation in response to DNA damage (Figure 12B). However, 
depletion of DUE-B, Orc2 or TopBP1 will result in attenuating the basal level of Chk1 
phosphorylation that occurs during DNA replication once, again verifying that DUE-B is one of 
the protein factors that is essential for DNA replication initiation. 
III. Dephosphorylated DUE-B is incorporated into high molecular weight complexes  
WT human DUE-B expressed in insect cells has many unique properties from that 
expressed in human cells. Endogenous DUE-B in asynchronous human cells and in G1 phase 
Xenopus egg extracts forms primarily homodimers. However, DUE-BSf9 was detected in high 
molecular weight complexes when incubated with Xenopus egg extract or HeLa nuclear extract. 
The only difference detected by mass spectrometry between DUE-BSf9 and DUE-BHeLa is that they 
are differently phosphorylated in the C-terminus 60 amino acids. Based on this observation, we 
hypothesized that the dephosphorylated DUE-BSf9 represented an intermediate state of 
endogenous DUE-B during a certain phase of the cell cycle when DUE-B is dephosphorylated.  
In order to study the relationship between DUE-B phosphorylation and high molecular 
weight complexes formation in vivo, we monitored DUE-B phosphorylation level during the cell 
cycle progression. We found DUE-B has the lowest phosphorylation level during the M phase of 
the cell cycle. After moving out of the M phase, DUE-B starts to get phosphorylated, which 
continues to the S-phase when DNA replication took place. After DNA replication completed, 
cells progress into M-phase and the DUE-B phosphorylation level goes back down. Consistent 
with the hypothesis, high molecular weight complexes containing DUE-B is observed in M phase 
and late S phase of the cell cycle when DUE-B phosphorylation level is low. This result indicates 
that dephosphorylated DUE-B gets incorporated into the high molecular weight complexes is a 
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naturally occurring process conserved in Xenopus and human cells. 
Because DUE-B protein level stays the same at all phases of the cell cycle, the fluctuation 
of the DUE-B phosphorylation level through out the cell cycle could have significant implication 
for regulating its function in DNA replication. Endogenous DUE-B is phosphorylated when the 
cells are preparing to initiate or during the process of DNA replication while the lowest 
phosphorylation level is when DNA replication is not active suggests that DUE-B 
phosphorylation positively correlates with DNA replication in the cell. In agreement with this 
result, phosphorylated DUE-BHeLa is fully capable of supporting DNA replication initiation but 
the dephosphorylated DUE-BSf9  is not able to support replication.  
 We showed that DUE-B dephosphorylation is correlated with high molecular weight 
complexes formation and losing the ability of supporting DNA replication. It was speculated that 
high molecular weight complexes formation is connected with the deficiency in supporting DNA 
replication. In order to answer this question, we examined the nature of the high molecular weigh 
complex. DUE-B was immunoprecipitated from the high molecular weight complexes and then 
subjected to mass spectrometry to identify the protein factors that bound to dephosphorylated 
DUE-B. Proteins identified by mass spectrometry belong mainly to three groups: chaperones, 
RNA binding proteins and the MCM2-7 complex subunits. Among these three groups, the MCM 
2-7 complex subunits are of most interest in terms of DNA replication. The interaction between 
DUE-B and MCM complex was confirmed by co-IP experiments and revealed that DUE-B 
directly interacts with Mcm3 and Mcm5. Interestingly, the MCM complex is exported from the 
nucleus during the G2-M phase of the cell cycle to prevent re-replication (Nguyen, Co et al. 2000; 
Tanaka and Diffley 2002). It is possible that dephosphorylated DUE-B binds to the MCM 
complex during the G2-M phase of the cell cycle and acts as a redundant mechanism to inhibit 
MCM activity especially during the mitosis when nuclear envelop is not available. Consistent 
with this hypothesis, data from previous lab members showed that DUE-BSf9 inhibits RPA 
chromatin loading, which suggests that the MCM helicase cannot be activated in the presence of 
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dephosphorylated DUE-B. More study is needed to understand the detailed mechanism of this 
interaction including the interaction domains and the MCM helicase activity after binding to 
DUE-BSf9. Additionally, Cdc45 or TopBP1 was not detected interacting with dephosphorylated 
DUE-B confirmed the previous conclusion that the interaction of DUE-B, Cdc45 and TopBP1 is 
a strictly regulated process and potentially only happens during the S phase of the cell cycle. 
IV. Kinase and phosphatase equilibrium controls DUE-B phosphorylation 
Different phosphorylation levels caused dramatic changes in the function of DUE-B. 
Previous lab members have shown that differently phosphorylated DUE-BSf9 and DUE-BHeLa  
have completely opposite effect on DNA replication. In this study, we showed that the DUE-B 
incorporation in to high molecular weight complexes is correlated with low phosphorylation level 
on DUE-B during the G2-M phase of the cell cycle. We hypothesized that the phosphorylation 
event released DUE-B from the high molecular weight complexes. In order to provide direct 
evidence that DUE-B phosphorylation regulates its incorporation in high molecular weight 
complexes, the DUE-BSf9 incubated with G1 phase egg extract was used as model system. 
Different treatment on DUE-B or enzymes in egg extract was carried out to identify the factors 
that alter DUE-B distribution.  
When DUE-BSf9 was incubated with untreated G1 phase egg extract, 36.5% of exogenous 
DUE-BSf9 was distributed in the high molecular weight complexes. When egg extract was 
supplemented with phosphatase inhibitors cocktail, only 24.4% of DUE-BSf9 was detected in the 
high molecular weight complexes. Phosphorylation of DUE-BSf9 by CKII further decreased the 
amount of DUE-BSf9 in high molecular weight complexes to 17.7%. This result strongly 
supported the hypothesis that phosphatase and kinase can regulate DUE-B interacting with other 
protein to form the high molecular weight complexes. Consistently, the endogenous DUE-B in 
G1 phase egg extract is sensitive to phosphatase treatment and a mobility shift was observed 
between DUE-B in the high molecular weight complexes and that in the dimer form.  
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Previous experiments have proved that DUE-BSf9 incubated in G1 phase egg extract as a 
valuable system that allows us to test the kinase and phosphatase activity in vitro without 
purifying active kinases or phosphatases. Using the same experiment setup, we tested a series of 
kinase and phosphatase inhibitors to identify the enzymes that are responsible for regulation of 
DUE-B phosphorylation. Protein phosphatase 2A and Cdc7 kinase were identified as the primary 
phosphatase/kinase pair controlling DUE-B phosphorylation in the G1 phase egg extract. 
Interestingly, casein kinase II was previously identified to phosphorylate DUE-B in vitro. We 
showed in this study that CKII primes DUE-B for DDK phosphorylation in G1 phase egg extract 
but does not directly release DUE-B from the high molecular weight complexes.  
DDK acts before CDK kinase in both yeast and Xenopus (Walter 2000; Heller, Kang et al. 
2011). The kinase activity of DDK starts as early as in G1 phase of the cell cycle, which renders 
it an ideal candidate kinase that phosphorylates and releases DUE-B from the high molecular 
weight complexes. The major known target of DDK in DNA replication initiation process is the 
MCM complex. It can phosphorylate every Mcm2-7 subunit except for the Mcm5. In a study 
trying to understand the mechanism of how DDK phosphorylates Mcm4 in yeast, DDK docking 
domain (DDD) was identified to be essential for Mcm4 phosphorylation by DDK. DDD in 
budding yeast Mcm4 physically interacts with DDK and thus aids DDK phosphorylating Mcm4 
(Sheu and Stillman 2006). Interestingly, when we compared the predicted Mcm4-DDD structure 
with the DUE-B N-terminus crystal structure using online tool PDBe Fold v2.51 
(http://www.ebi.ac.uk/msd-srv/ssm/ssmstart.html), two alpha helix structures were shown to be 
similar (Figure 47). It is possible that this similar structure in DUE-B binds to DDK and 
facilitates the phosphorylation at the DUE-B C-terminus. 
One would argue that DDK does not directly phosphorylate DUE-B. Under the experiment 
condition tested, the accumulation of DUE-B in high molecular weight complexes could be a 
result of DUE-B binding with unphosphorylated MCM or other unidentified DDK substrate. 
However, this is very unlikely to be true because all potential DDK substrates are incubated in the  
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Figure 47. Structural analysis of DUE-B N-terminus and MCM4-DDK docking site 
(A) Crystal structure of DUE-B N-terminus 151 residues from RCSB protein data bank sequence 
2OKV. Fragments colored in blue indicate the structures similar to Mcm4 DDD domain. (B) 
Crystal structure of Mcm4 DDD domain from RCSB protein data bank sequence 1LTL. 
Fragments colored in blue indicate the structures similar to DUE-B N-terminus. (C) Structure 
alignment using online tool PDBe Fold v2.51. http://www.ebi.ac.uk/msd-srv/ssm/ssmstart.html 
A                                       B 





G1 phase egg extract before adding PHA-767491, if DDK would phosphorylate any of these 
substrates in G1 phase egg extract, they should have already been phosphorylated when preparing 
the egg extract before DDK was inhibited by PHA-767491. Direct phosphorylation of DUE-B 
using purified DDK is still needed to prove this idea directly. 
We have shown that PP2A is responsible to dephosphorylate DUE-B and increase its 
accumulation in the high molecular weight complexes. Because DUE-B is phosphorylated during 
the G1-S phase and is less phosphorylated in G2-M phase of the cell cycle, we propose that PP2A 
dephosphorylates DUE-B after DNA replication finished. However, our data also suggested that 
PP2A is active in G1 phase egg extract. Consistent with this finding, prior study in Xenopus egg 
extract suggested that PP2A activity is necessary for Cdc45 chromatin loading (Chou, Petersen et 
al. 2002). We also showed that PP2A activity is required for DUE-B chromatin loading in egg 
extract. It is possible that the fluctuation of DUE-B phosphorylation level reflected on Western 
blot is a net result from the equilibrium of DDK and PP2A. During the G1-S phase of the cell 
cycle, the DDK activity dominants the PP2A activity, and the equilibrium shifts towards more 
phosphorylated DUE-B. During the G2-M phase, PP2A outweighs the DDK kinase activity and 
results in decreases of the DUE-B phosphorylation level. It is worth mentioning, the equilibrium 
between kinase and phosphatase might be essential for the enzymatic function of DUE-B during 
the S-phase of the cell cycle. A small amount of DUE-B could undergo rapid phosphorylation and 
dephosphorylation cycle and carry Cdc45 to the chromatin.  
Interestingly, under all tested conditions, only DUE-BSf9 is sensitive to the 
kinase/phosphatase inhibitor treatment suggesting that there might be another level of regulation 
which controls DUE-B activity. Because endogenous DUE-B migrates as a single band at 23.4 
kD on SDS PAGE, which is the exact predicted size of WT DUE-B, it is less likely that 
monoubiquitylation or glycosylation would account for this regulation. Previous mass 
spectrometry analysis did not reveal any posttranslational modification other than 
phosphorylation on DUE-BSf9 or DUE-BHeLa. It is possible that endogenous DUE-BXl might have 
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different phosphorylation pattern that makes it less sensitive to PP2A in G1 phase of the cell 
cycle. 
V. C-terminus domain is important for DUE-B function 
The DUE-B C-terminus domain is rich in serine and threonine. Also, the C-terminus domain 
is shown to be disordered in structure, which makes it ideal target for protein-protein interaction 
and target of post translational modification (Iakoucheva and Dunker 2003). Previous lab member 
and this study showed that CKII and Cdk2 phosphorylate DUE-B at the C-terminus tail. 
Additionally, 4 conserved DDK targeting sites are also present in the C-terminus domain. Some 
of these phosphorylation sites are overlapping with each other. For example, serine 205 can be 
phosphorylated by both CKII and DDK. Moreover, as discussed before, phosphorylation at one 
residue could determine the phosphorylation of the other residue. Importantly, most of the S/T 
residues in the C-terminus domain are very conserved in higher organisms suggesting the 
importance of their function. Several mutants were created in order to study the function of C-
terminus domain. 
By tagging DUE-B mutants with YFP, we found WT DUE-B and ΔCT DUE-B have distinct 
subcellular localization. WT DUE-B primarily localizes in the cytoplasm while the ΔCT DUE-B 
stays in the nucleus. This result suggests that the C-terminus domain has the function of 
regulating DUE-B subcellular localization potentially through controlling the protein that DUE-B 
interacts with. Changing subcellular localization is a shared mechanism by many DNA 
replication proteins to regulate their function. For example, Cdt1 and Mcm2-7 accumulate in the 
nucleus during G1 phase and are excluded from the nucleus later in the cell cycle (Tanaka and 
Diffley 2002). More study is needed to understand how phosphorylation would affect DUE-B 
subcellular localization. 
When overexpressing the C-terminus unphosphorylatable S/T to A mutant (STA), the cells 
showed severe growth defect even in the presence of endogenous DUE-B. This is potentially 
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caused by the inability of STA mutant in supporting DNA replication similar to the situation seen 
with DUE-BSf9. Overexpressing STA mutant causes difficulties in progressing through S phase of 
the cell cycle. Incubating the STA mutant expressed in HeLa cells blocks DNA replication 
initiation in Xenopus egg extracts. On the contrary, if the S/T residues in the STA mutant were 
replaced with the phosphomimetic aspartate (STD), cells showed no growth defect when 
overexpressing this STD mutant. Similarly, cells expressing C-terminus 60 amino acids deletion 
mutant (ΔCT) did not have defect in progressing through the cell cycle. Incubating the ΔCT 
DUE-B purified from human cells would not inhibit DNA replication in Xenopus egg extract 
either. These data suggest that phosphorylation at DUE-B C-terminus domain is important for 
regulating its function in vivo.  
Strikingly, when DUE-B mutants were synthesized in vitro, they presented completely 
different properties than those expressed in HeLa cells. All the in vitro translated proteins 
inhibited DNA replication when incubated with egg extract indicating that the in vitro translated 
proteins do not carry the same posttranslational modifications as those purified from HeLa cells. 
Although limited information concerning DUE-B function in vivo can be obtained using the in 
vitro translated proteins, we still observed that STA mutant has complete opposite effect from the 
STD mutant. This finding suggests that phosphorylation at the C-terminus domain could still be 
regulating the function of the whole protein regardless of the posttranslational modification on the 
rest of the protein.  
Structure predictions using the DisEMBL program provided possible explanation to the 
regulatory effect of DUE-B C-terminus phosphorylation. The STA mutants significantly 
decreased the disorder at the C-terminus domain. WT and STD mutants have similar level of C-
terminus disorder. Illustrated in Figure 48, it is possible that when DUE-B is phosphorylated, the 
C-terminus tail is kept in relaxed states. The disordered C-terminus domain exposes the N-
terminus of the protein and thus allows the N-terminus to carry out its function. On the other 
hand, when C-terminus S/T residues are phosphorylated, the C-terminus domain folds back onto  
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the N-terminus and blocks the N-terminus activity. However, phosphorylation at the individual 
serine and threonine residues could have different function in regulating DUE-B activity. More 
research is still needed to study the physiological significance of phosphorylation at each residue.  
VI. Regulation DUE-B activity during the cell cycle 
Data presented in this study can be summarized in Figure 49. DUE-B is constantly regulated 
by phosphorylation during the cell cycle. Phosphorylation of DUE-B is mainly controlled by the 
equilibrium between DDK and PP2A. In G2-M phase, when PP2A activity overwhelms the DDK 
kinase activity, DUE-B phosphorylation level decreases. Dephosphorylated DUE-B binds with 
other proteins, including the MCM helicase, to form high molecular weight complexes. Binding 
with dephosphorylated DUE-B inhibits MCM complex activity, which acts as one of the multiple 
mechanisms preventing DNA replication initiation in the G2-M phase of the cell cycle. After 
cells proceed through M phase and prepare to enter the next cell cycle, DUE-B gets 
phosphorylated as a result of elevated DDK activity. Phosphorylation of DUE-B is regulated by 
multiple kinases, among which CKII primes DUE-B for DDK phosphorylation while checkpoint 
kinases inhibits DDK activity. DUE-B phosphorylation during the G1 phase disassociates the 
high molecular weight complexes and consequently frees both DUE-B and MCM from the 
inactive complex. MCM complex is loaded onto chromatin in G1 phase then DUE-B is loaded 
onto the chromatin after pre-RC is formed. High level of phosphorylation on DUE-B persists 
throughout the S phase when cells replicate their DNA. After DNA replication has finished, 
DUE-B is dephosphorylated again by PP2A. 
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CONCLUSIONS 
DUE-B is an important DNA replication factor that is necessary for Cdc45 chromatin 
loading during replication initiation. In this study, we showed that DUE-B binds to chromatin 
after pre-RC formation and requires CDK kinase activity. DUE-B chromatin binding is 
negatively regulated by checkpoint response triggered by different replication challenging agents. 
Since DUE-B protein level stays constant during the cell cycle, its function is regulated by 
posttranslational modifications. DDK and PP2A are the primary kinase/phosphatase pair that 
governs DUE-B phosphorylation level. DUE-B is dephosphorylated in G2/M phase of the cell 
cycle while high level of phosphorylation is detected in G1/S phase. Dephosphorylated DUE-B is 
incompatible with DNA replication potentially because its inability of binding with Cdc45 and 
TopBP1. Additionally, dephosphorylated DUE-B dominantly inhibits DNA replication possibly 
through inhibiting MCM activity. Phosphorylation of DUE-B at the C-terminus controls DUE-B 
activity in DNA replication. Together, DUE-B is an important DNA replication factor and is 
actively regulated by different kinases and phosphatase in the cell.  
	    
138	  
APPENDICES 
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Appendix 2. Optimizing nocodazole concentration and centrifugation condition to inhibit 
non-specific precipitation in Xenopus egg extract system.  
(0’) samples were taken at 0’ while all the rest samples were collected after 31minutes incubation 
at room temperature. All the samples were spun trough 0.7 M sucrose cushion. Result suggests 
that increasing concentration and lower centrifugation speed can help prevent protein aggregation 
and nonspecific signal in protein chromatin loading experiments. It might be necessary to re-test 
the optimal Nocodazole concentration when using different batches of egg extract because the 
efficient concentration of Nocodazole varies between batches. Also, it is preferred to keep 
Nocodazole stock solution in small aliquots to avoid repeat freeze and thaw cycle. Generally, a 
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Appendix 3. Site directed mutagenesis  
A 
Template: 
DUE-B WT          5'…GACCATAGAGCTGGAATCGCCAGCTCCCGGCAC…3’ 
 
Target: 




DUE-B(S147A)f           5’-AGAGCTGGAAgCGCCAGCTCCCGGCAC-3’                       
DUE-B(S147A)b-rev 3’-CTGGTATCTCGACCTTcGCGGTCGAGG-5’ 




DUE-B WT:      
5’-GAGACCCAAGCTGGCTAGTTAAGCTTGGTACCGAGCTCGGATCCGATGAAGGCCGTGGTGCAGC-3’ 
Target: 
FLAG DUE-B  
5’…AGCTGGCTAGTatggactacaaggacgacgatgataagATGAAGGCCGTGGTG…3’ 
Primers: 
FLAG FW: 5'-gacgatgataagATGAAGGCCGTGGTGCAGC-3’ 
FLAG RV: 5'-gtccttgtagtccatACTAGCCAGCTTGGGTCTC-3’ 
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Appendix 4. Testing TopBP1 antibody WRSU5 rabbit serum was made by Casey Wells.  
The peptide used in this project was from human TopBP1 sequence. This test indicates WRSU5 
serum also contains antibody that reacts with Xenopus TopBP1 and can be used in co-IP 
experiments. 100ul LSS egg extract was incubated with 20ul protein G beads conjugated with 2ul 
rabbit serum at 4 degree for 2 hours. Beads were then washed with egg lysis buffer for 5 times. 
1ul depleted egg extract or beads were separated by SDS PAGE.  
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Appendix 7. Chemical tolerance test of Xenopus egg extract  
Xenopus egg extract is sensitive to the chemical used in protein purification and protein storage. 
Here, I have tested a serious of chemicals with concentrations and their effect on DNA replication 
in Xenopus egg extract. All the proteins used in this study were cleaned and free of these 
chemicals before adding into egg extract. Care should be taken in the future study to remove 
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Appendix 8. Plasmids used in this study. 
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